CA2190696A1 - Protective coating for a stent with intermediate radiopaque coating - Google Patents
Protective coating for a stent with intermediate radiopaque coatingInfo
- Publication number
- CA2190696A1 CA2190696A1 CA2190696A CA2190696A CA2190696A1 CA 2190696 A1 CA2190696 A1 CA 2190696A1 CA 2190696 A CA2190696 A CA 2190696A CA 2190696 A CA2190696 A CA 2190696A CA 2190696 A1 CA2190696 A1 CA 2190696A1
- Authority
- CA
- Canada
- Prior art keywords
- stent
- radiopaque
- protective layer
- layer
- tubular body
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/082—Inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/18—Materials at least partially X-ray or laser opaque
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0077—Special surfaces of prostheses, e.g. for improving ingrowth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
- A61F2002/072—Encapsulated stents, e.g. wire or whole stent embedded in lining
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/0013—Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0096—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
- A61F2250/0098—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers radio-opaque, e.g. radio-opaque markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00011—Metals or alloys
- A61F2310/00035—Other metals or alloys
- A61F2310/00155—Gold or Au-based alloys
Abstract
The invention relates to coated stents and the method of making them. A stent that is substantially radiolucent is at least partially coated with a radiopaque layer that makes the stent visible under X-ray or fluoroscopy. A protective layer is coated on the stent and the radiopaque layer to protect both from scratches, flaking, and galvanic corrosion, and to improve both blood and bio-compatability.
Description
21 906~6 Docket No . ACS 4 0 3 6 8 BACKGROUND OF THE INVENTION
The invention relates generally to stents, and more particularly to coatings applied to stents to make the same radiopaque and coatings to protect the stent and the radiopaque layer.
Stents are useful in the treatment of atherosclerotic stenoses in blood vessels and are generally tubular shaped devices which function to hold open a segment of a blood vessel, artery, heart valve or other body lumen. Stents are particularly suitable for use in supporting and holding open a coronary artery after an atherectomy or angioplasty procedure.
Generally, stents are made from a metal alloy, such as stainless steel, and have a hollow tubular shape with an outer wall surface resembling an open lattice configuration.
In some prior art stents, the outer wall surface comprises intersecting wires or struts that are expanded beyond the elastic limit thereof to plastically deform and hold open the body lumen in which they are implanted. Other stents are self-expanding and can be in the form of a coil wire that is biased open.
Stents made from stainless steel, for example, are radiolucent, due in part to the intersecting wires having a diameter of about 0.076 mm (0.003 in.) or less. Unless the metal or metal alloy used for making the stent has a high atomic weight and density, it is difficult to visualize ln vivo during catheter introduction into the vessel, stent deployment, and post-operative diagnosis.
At least one prior art stent has an increased wire diameter, to approximately 0.102 mm (0.004 in.), in order to make the stent more radiopaque. The disadvantages of a stent having thicker intersecting wires is a more rigid stent that tracks poorly through a tortuous vessel, a stent which is virtually inflexible when tracking on a curved section of vessel, a stent that cannot be implanted easily in a curved section of a vessel, a stent which may not deploy in a uniform cylindrical shape, and a stent with poor hemodynamics. The --2- Docket No. ACS 40368 latter disadvantage, poor hemodynamics, can result in serious medical complications such as thrombosis.
SUMMARY OF THE INVENTION
The disadvantages of the prior art stents are overcome by the present invention in which a stent is provided that is sufficiently radiopaque, flexible, has a low profile, is substantially non-thrombogenic, and has a protective layer that will eliminate corrosion while still protecting the stent and other layers from mishandling.
A stent embodying the present invention includes an elongated tubular body that is substantially radiolucent and is formed from, for example, a stainless steel alloy. In order to increase the radiopacity of the stent, without the disadvantages of thicker wires, the stent, or a portion thereof, is coated with a thin radiopaque layer of material having high atomic weight, high density, sufficient surface area ànd sufficient thickness. With such a coating, the stent is sufficiently radiopaque to be seen with fluoroscopy, yet not so bright as to obstruct the radiopaque dye. This radiopaque layer covers at least a portion of the stent and can be formed from gold, tantalum, platinum, bismuth, iridium, zirconium, iodine, titanium, barium, silver, tin, alloys of these metals, or similar materials.
The radiopaque layer is thin, in one preferred embodiment it is about 1.0 to 50 microns thick. Because the layer is so thin, it is subject to scratching or flaking when the stent is being delivered intraluminally. Accordingly, it is an object of the invention to protect the stent and particularly the radiopaque layer with a more durable protective layer that is resistant to scratching and general mishandling.
Whenever two dissimilar metals are in direct contact, such as a stainless steel stent at least partly covered with a gold radiopaque layer, there is the potential to create the electrochemical reaction that causes galvanic corrosion. The 21 906q6 --3-- Docket No . ACS 40368 by-product of corrosion (i.e., rust) will not be biocompatible or blood compatible, may cause a toxic response, and may adversely affect adhesion of the radiopaque material.
Corrosion will occur if gold and another metal, like stainless steel, are in contact with the same bodily fluid (electrolyte).
If the gold coating has any pinholes or has a flaked or scratched-off surface, the underlying stainless steel will be exposed to the same fluid. Therefore, a galvanic reaction (i.e., a battery effect) will occur. The use of a single protective coating covering the entire surface prevents this reaction. This is especially pertinent when the radiopaque layer partially covers the stainless steel stent. The protective layer of the present invention also prevents galvanic corrosion so that the stent is biocompatible.
In one embodiment of the invention, a separate radiopaque layer can be eliminated by incorporating a radiopaque material, such as barium or titanium oxide, into the protective layer. In this embodiment, the stent is visible under fluoroscopy and it is protected by the protective layer, yet it will have a lower profile since it lacks a separate radiopaque layer.
The invention also includes the method of making the stent and of applying a radiopaque layer and a protective layer to it. The radiopaque coating can be applied by dipping, spraying, painting, electroplating, evaporation, plasma vapor deposition, cathodic arc deposition, sputtering, laser welding or fusing, resistance welding, and ion implantation. The protective layer can be applied by dip coating, spray coating, spin coating, plasma deposition, condensation, electro-chemically, electrostatically, electroplating, evaporation,plasma vapor deposition, cathodic arc deposition, sputtering, ion implantation, or use of a fluidized bed. The process for applying the radiopaque layer and the protective layer depends upon numerous factors which can include the type of material comprising the layer. These and other advantages of the invention will become more apparent from the following detailed description thereof and the accompanying exemplary drawings.
--4-- Docket No. ACS 40368 BRIEF DESCRIPTION OF THE DRAWINGS
FIGURE 1 is a perspective view depicting a stent having an open lattice structure and covered with both a radiopaque layer and a protective layer.
FIG. 2 is a cross-sectional view of the stent of FIG. 1 taken along lines 2-2, depicting the stent covered by a radiopaque layer and a protective layer over the radiopaque layer.
FIG. 3 is a cross-sectional view of one of the wires of the stent of FIG. 2 taken along lines 3-3, depicting the stent wire being coated with a radiopaque layer and a protective layer.
FIG. 4 is a perspective view of a stent having an open lattice structure and being partially covered by a radiopaque layer and completely covered by a protective layer.
FIG. 5 is a cross-sectional view taken along lines 5-5 of the stent of FIG. 4, depicting a partial radiopaque layer on the stent, covered by a protective layer.
FIG. 6 is a cross-sectional view taken along lines 6-6 of the stent of FIG. 5, depicting a straight portion of astent wire having a radiopaque layer covered by a protective layer.
FIG. 7 is a cross-sectional view of the stent of FIG.
5 depicting a stent having a protective layer with a radiopaque agent incorporated in the protective layer.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
A stent embodying the invention is intended for either temporary or permanent deployment in a body lumen such 21 906~6 -5-- Docket No. ACS 40368 as a coronary artery, carotid artery, vessels in the brain, aorta, peripheral arteries and veins, and the like. The stent also can be deployed in the urethra and other body lumens. The stent is used primarily to support the body lumen so that it remains patent and permits the uninterrupted flow of blood or other body fluids. It is important for purposes of delivery, deployment and post-operative diagnosis that the stent be both visible and remain biocompatible. A stent embodying the invention is visible due to a radiopaque layer and it remains biocompatible due its protective layer.
A stent that is made by known etching processes or laser cutting a metal tube, or by winding a metal wire(s), must be sufficiently thick to be radiopaque under X-ray or fluoroscopy ln vivo. Generally, current stent designs include an open lattice structure of interwoven wires or struts or coils that are made from stainless steel or other metals or metal alloys that are radiolucent due to a wire thickness or cross-section of about 0.076 mm (0.003 in.) or less. Unless the mètal or alloy used for making the stent has high atomic weight and density, it is difficult to visualize the stent ln vivo during catheter introduction into the vessel (artery, vein, urethra, etc.), stent deployment, and post-operative diagnosis. Another solution to increase radiopacity of the stent is to increase the strut or wire cross-section to approximately 0.102 mm (0.004 in.), however, this will result in a substantially more rigid stent having poor hemodynamics.
Therefore, coating the stent with a thin layer of material having high atomic weight, high density, sufficient thickness (15 microns or less), and large surface area will have an effect similar to that of thickening the stent. It will make the stent sufficiently radiopaque so that it can be seen, ln vivo but not so radiopaque to obstruct the view of radiopaque dye. The coating can be high atomic weight material such as gold, tantalum, platinum, bismuth, iridium, or the like. It also can be lower atomic weight material like zirconium, iodine, titanium, barium, silver, tin, or the like.
For the latter-type coatings, a thicker coating may be needed 21 9069~
-6-- Docket No. ACS 40368 to make the stent sufficiently radiopaque. In either case, a thin coating will allow the stent to remain thin and flexible while maintaining a low stent profile to minimize disruption of blood flow.
On the other hand, thickening the stent or changing the material used for making the stent to a more radiopaque material (i.e., tantalum, gold, etc.) may lead to poor stent performance. A thicker, high profile stent may result in areas of stagnation, turbulence, separation of flow, or other unacceptable fluid dynamics that can promote thrombogenesis.
A thicker stent has lower fatigue resistance due to its brittleness. A tantalum stent is brittle and cracks easily.
A gold stent will be prohibitively expensive and too ductile.
In the thickness range of less than 0.076 mm (0.003 in), a gold stent will not have sufficient strength to support the artery or body lumen. Both will be too radiopaque (stent made from all tàntalum or gold) and will obstruct the view of radiopaque dye when it flows through the lumen of the stent. Allowing visualization of the dye flowing through the stent lumen is important for diagnostics. Dye flowing through the stent lumen provides information to the clinician about restenosis, the size of artery, the size of the stent lumen during and after deployment, and the presence of dilation or other important parameters necessary for the care of the patient. This avoids the need for post-insertion and post-operative ultrasound detection procedures necessary to determine the diameters of the stent and vessel lumen. Therefore, a thin radiopaque coating is preferred over a stent made entirely from a highly radiopaque material.
Gold is the preferred radiopaque coating because of its high atomic weight and density, both of which contribute to its radiopacity. In addition, gold is a highly ductile metal and therefore, resists cracking when the stent is stressed during deployment or fatigue after deployment. A thin gold coating (less than 15 microns) is sufficient to absorb enough energy to be opaque when exposed to X-rays. Equivalent radiopacity cannot be achieved with a stent made from stainless 21 906q6 -7-- Docket No. ACS 40368 steel or the like unless the stent is at least twice the thickness. Studies have shown that a 2.0 to 3.0 micron gold coating (or other metal) on a 0.058 mm (0.0023 in.) thick 316L
stainless steel stent (l.e., where the diameter of the wires or 5 struts is 0. 058 mm (O. 0023 in.)) is sufficient to elevate the radiopacity to make it equivalent in radiopacity to a 0.102 mm (0.004 in.) thick 316L stent.
When dissimilar metals come in contact, such as the gold 'radiopaque coating on a stainless steel stent, the potential to initiate galvanic corrosion exists. This phenomenon occurs when two electrochemically dissimilar metals come in contact with each other. In addition, the radiopaque coating may be less biocompatible than the stent material and may induce thrombosis and stenosis after its deployment.
15 Furthèrmore, the radiopaque coating is prone to scratching and handling mishaps resulting in scratches, a chipped coating, flaking, or other defects. Surface irregularities on these coatings may act as loci for unwanted platelet adhesion or cell lysis.
In order to reduce galvanic corrosion and protect the coating, it is essential to coat the outermost surface of the stent (already coated with a radiopaque coating) with a protective coating. The protective coating provides a protective barrier against mishandling, prevents the 25 electrochemical reaction that causes galvanic corrosion, and is blood and tissue compatible. It is thin and flexible such that it wiil not crack during stent deployment. It will hide any flaws that are on the surface of the stent and prevent any extraordinary events from occurring. In addition, it has a 30 lower coefficient of friction than most stent materials. A
hydrogel layer also can be applied on the inside and/or outside surface of the stent by chemically bonding it to this protective coating. The hydrogel coating then can act as a buffer between the stent and vessel, minimizing vascular 35 injury.
In the preferred embodiment of the invention, as depicted in Figs. 1-2, the stent 10 is a generally cylindrical --8-- Docket No. ACS 40368 member having an elongated tubular body 11 with an outer surface 12 and an inner surface 13. When the stent 10 is made from a material that is substantially radiolucent, it is important to increase its radiopacity. In order to increase the visibility of the stent 10, a radiopaque layer 14 is applied to coat all of the stent 10, including the outer surface 12 and the inner surface 13. Typically, the stent 10 will be made from a plurality of intersecting struts or wires 15 that can be formed by known methods as described herein. In this embodiment, the radiopaque layer 14 is applied so that it covers all portions of the struts or the wires 15. As is shown in Fig. 3, the radiopaque layer 14 surrounds the strut 15 so that its radiopacity is ensured. It is preferred that the radiopaque layer 14 have a uniform thickness in the range of 1.0 to 50 microns and, more preferably, in the range of from 1.5 to 10 microns. If the radiopaque layer 14 is too thick, it also may result in the stent 10 being too bright under fluoroscopy and it may interfere with the expansion of the stent. Thus, the thickness of radiopaque layer should be uniform and in the preferred thickness ranges, depending upon such factors as the type of metal in the stent, where it will be implanted, the diameter of the struts 15, and the like.
In keeping with the preferred embodiment, as shown in Figs. 1-3, a protective layer 20 covers and surrounds the radiopaque layer 14 and protects it against scratches, flaking, and other mishandling. Generally, the radiopaque layer 14 will be formed from a relatively soft and malleable metal such as gold, and it is subject to scratching and flaking both before it delivered in the patient and after it is mounted on a catheter and delivered intraluminally. Thus, the protective layer 20 will provide a durable coating to protect the radiopaque layer.
As will almost always be the case, the stent 10 and the radiopaque layer 14 will be formed from dissimilar metals which may initiate the chemical reaction leading to galvanic corrosion. The protective layer 20 completely coats the --9-- Docket No. ACS 40368 radiopaque layer 14 thereby eliminating any likelihood of galvanic corrosion.
In another preferred embodiment, as seen in Figs. 4-6, the stent 10 is only partially coated by a partial radiopaque layer 30. Portions of the stent 10 are coated with the partial radiopaque layer 30, while the stent portion 31, which is curved, is not covered by a radiopaque layer. It is noted that the scale of the partial radiopaque layer 30 to the stent struts 33 and the protective layer 34 is somewhat out of proportion for ease of illustration. Typically, as has been demonstrated in experiments, the partial radiopaque layer 30 is applied to straight sections 32 of the struts 33 so that the stent can be expanded without distortion. Many commercial stents have curved sections and curved struts that will twist and deform if the radiopaque layer is applied to the curved section, since the radiopaque layer actually adds some rigidity to the stent. Thus, it is preferred that the partial radiopaque layer 30 be applied to the non-curved struts of the stent. In other stent configurations, it may not matter where the partial radiopaque layer 30 is applied on the stent 10.
The primary reason for the radiopaque layer is to enhance the visibility of the stent, but it should not interfere with stent expansion.
In the preferred embodiment shown in Figs. 4-6, the stent 10 is coated by the protective layer 34, which actually covers the stent portion 31 and the partial radiopaque layer 30. The protective layer 34 protects the partial radiopaque layer 30 as described above, and it eliminates the possibility of gàlvanic corrosion when the stent 10 and the partial radiopaque layer 30 are dissimilar metals.
In an alternative embodiment, the protective layer 34 covers only the partial radiopaque layer 30 and does not cover those portions of the stent 10 where there is no radiopaque coating. Thus, using FIG. 4 as an example, the partial radiopaque layer 30 is applied to straight sections 32 and the protective coating 34 is selectively applied to cover the partial radiopaque layer 30 only.
21 ~0696 --10-- Docket No. ACS 40368 The radiopaque coating can be made from solid metal (i.e., gold, silver, tin, tantalum, zirconium, platinum, or other metals), ceramic (Zirconia, alumina, zirconium nitrate, titanium nitrite, graphite, pyrolytic carbon, NEDOX, or other ceramics), metal/ceramic-filled particles dispersed in a polymer matrix, or other radiopaque material. The radiopaque coating can be coated anywhere on the stent. It can partially cover the stent (one or more bands, longitudinal continuous or discontinuous band, dots, outside surface only, inside surface only, etc.) or fully cover the stent.
In the preferred method of applying the radiopaque layer 14 or the partial radiopaque layer 30, a radiopaque coating can be applied by dipping, spraying, painting, electroplating, evaporation, plasma vapor deposition, cathodic arc deposition, sputtering, ion implantation, laser welding or fusion, resistance welding, or other methods. The thickness of the radiopaque coating generally is 50 microns or less. The coating can be applied on the inside and/or outside surface of the stent or it can fully encapsulate the stent strut(s).
For instance, a band of gold coating can be placed around the stent at the ends by first completely masking the stent with alkaline or acid-resistant mask material (i.e., the - material manufactured under the tradename "MICROSTOP" by Pyramid Chemical Company, polyesters, acrylic, wax, etc.). The type of mask material depends on what coating process is to be used. After the stent has been masked, the mask is removed preferentially from the stent surface, using a laser, sandblaster, or other appropriate method. Any pattern can be made by selectively removing mask material. The exposed surface (non-masked areas) then can be coated with radiopaque material by the above-described methods (i.e., electroplating).
Other masking techniques also are possible (i.e., physical, chemical, or mechanical). In addition, prefabricated gold markers also can be laser-fused or resistance-welded to the stent at any specific locations. Further details of applying a radiopaque layer to a stent are found in co-pending, U.S.
Serial No. 08/564,936.
21 9069~
--11-- Docket No. ACS 40368 In the preferred method of applying the protective layer 30,34, the biocompatible and blood-compatible protective layer can be polymeric, "PARYLAST", polymethylene, metallic, or ceramic. A polymeric layer (i.e., parylene, polycarbonate-urethane copolymer, silicone rubber, hydrogels, polyvinylalcohol, polyvinyl acetate, polycapralactone, urethanes, PHEMA-Acrylic, etc.) can be applied onto the radiopaque-coated stent by dip-coating, spray-coating, spin-coating, plasma deposition, condensation, electrochemically, electrostatically, or other suitable methods. "PARYLAST" is a preferred protective coating and is distributed by Advanced Surface Technology Corp. A
metallic coating (i.e., titanium and tantalum) can be applied by electroplating, evaporation, plasma-vapor deposition, cathodic-arc deposition, sputtering, ion implantation, electrostatically, electrochemically, a combination of the above, or the like. A ceramic coating (l.e., zirconium nitrite, pyrolytic carbon, graphite, a material sold under the tradename "NEDOX" by the General Magnaplate Corporation, and titanium nitrite) can be applied by the use of a fluidized bed, spraying, plasma-vapor deposition, evaporation, sputtering, electrochemically, electrostatically, a combination of the above, or the like. The thickness of the protective layer preferably is from .01 to 25 microns.
In an alternative preferred embodiment, as shown in Fig. 7, the stent 10 is at least partially covered by a protective coating 40 which is itself radiopaque. The protective coating 40 is loaded with radiopaque agents such as barium, titanium oxide, and the like. Further, multiple layers of the protective layer can be applied to the stent where the first layers are loaded with radiopaque agents while the outermost protective layer is not loaded with a radiopaque agent.
In another embodiment, not shown in the drawings, the protective layer is first applied to cover the stent and the radiopaque layer is applied to partially or completely cover the protective layer. In this embodiment, the radiopaque layer is scratch resistant and biocompatible.
- 21 906~
--12-- Docket No. ACS 40368 A protective layer has been described herein as a mechanical barrier which protects against mishandling, electrochemical reaction that causes galvanic corrosion, and against adverse blood and tissue response. It also is important that the protective layer form a conformal coating that will adhere to the stent surface. When there is no adhesion, any stretching and straining of the stent may lead to a rupture of the protective layer, resulting in folds at the strained areas (like elephant skin folds) which may lead to a penetration of blood and tissue causing an adverse response, or causing galvanic corrosion.
Thus, with respect to all of the protective layers disclosed herein, the process to improve adhesion between the protective coating and the substrate (the radiopaque layer) is desired. One such process is to deposit a thin intermediate layer or layers from the silane group or to plasma deposit a polymer from a gaseous organic such a methane, xylene or gases from the silane or titanate groups. A preferred method is to deposit "PARYLAST," a coating which incorporates the deposition of an intermediary followed by parylene C in the same processing chamber. In addition to an intermediary layer, improved adhesion can be attained by reducing the thickness of the protective coating. Thinner coatings tend to be more flexible, especially when the material has a glass transition temperature above room temperature. Thus, thinner coatings adhere better.
Thus, a preferred method is to deposit "PARYLAST,"
a parylene C coating, which incorporates the addition of an intermediary in the same process chamber.
Another method for improving the adhesion between the protective layer and the radiopaque layer is by acid treatment, sandblasting, or similar methods. These methods allow a mechanical interlocking between the substrate and the protective layer.
"PARYLAST" can be coated at different thicknesses that can vary from 0.013 mm to 0.0025 mm (.00005 in. to .0001 in.). It is preferred that the thickness of the "PARYLAST" be --13-- Docket No . ACS 40368 at least 0.0025 mm (0.0001 in.) in order to minimize the potential for pinhole formation, while maintaining the optimum flexibility (thicker coatings may be too rigid and affect stent expansion). The degree of texture on the substrate may vary from 1 to 250 micron average pore sizes. It is preferred that the substrate have a 1-6 micron average pore size. At larger pore sizes, the textured surface is retained on the coated surface after parylene C or a "PARYLAST" treatment.
After the protective layer is applied on the surface, other coatings that may be more blood compatible also can be applied. For example, coatings such as the one sold under the tradename "DUROFLO," manufactured by the Bentley Company, and the one sold under the tradename "PHOTOLINK HYDROGEL,"
manufactured by the BSI Corporation, and the one sold under the tradename "PHOTOLINK HEPARIN," also manufactured by the BSI
Corporation, or similar coatings, can enhance the blood compatibility of the stent.
While several particular forms of the invention have been illustrated and described, it will also be apparent that various modifications can be made without departing from the scope of the invention. Thus, it should be understood that various changes in form, and detail, and application of the present invention may be made without departing from the scope of this invention.
The invention relates generally to stents, and more particularly to coatings applied to stents to make the same radiopaque and coatings to protect the stent and the radiopaque layer.
Stents are useful in the treatment of atherosclerotic stenoses in blood vessels and are generally tubular shaped devices which function to hold open a segment of a blood vessel, artery, heart valve or other body lumen. Stents are particularly suitable for use in supporting and holding open a coronary artery after an atherectomy or angioplasty procedure.
Generally, stents are made from a metal alloy, such as stainless steel, and have a hollow tubular shape with an outer wall surface resembling an open lattice configuration.
In some prior art stents, the outer wall surface comprises intersecting wires or struts that are expanded beyond the elastic limit thereof to plastically deform and hold open the body lumen in which they are implanted. Other stents are self-expanding and can be in the form of a coil wire that is biased open.
Stents made from stainless steel, for example, are radiolucent, due in part to the intersecting wires having a diameter of about 0.076 mm (0.003 in.) or less. Unless the metal or metal alloy used for making the stent has a high atomic weight and density, it is difficult to visualize ln vivo during catheter introduction into the vessel, stent deployment, and post-operative diagnosis.
At least one prior art stent has an increased wire diameter, to approximately 0.102 mm (0.004 in.), in order to make the stent more radiopaque. The disadvantages of a stent having thicker intersecting wires is a more rigid stent that tracks poorly through a tortuous vessel, a stent which is virtually inflexible when tracking on a curved section of vessel, a stent that cannot be implanted easily in a curved section of a vessel, a stent which may not deploy in a uniform cylindrical shape, and a stent with poor hemodynamics. The --2- Docket No. ACS 40368 latter disadvantage, poor hemodynamics, can result in serious medical complications such as thrombosis.
SUMMARY OF THE INVENTION
The disadvantages of the prior art stents are overcome by the present invention in which a stent is provided that is sufficiently radiopaque, flexible, has a low profile, is substantially non-thrombogenic, and has a protective layer that will eliminate corrosion while still protecting the stent and other layers from mishandling.
A stent embodying the present invention includes an elongated tubular body that is substantially radiolucent and is formed from, for example, a stainless steel alloy. In order to increase the radiopacity of the stent, without the disadvantages of thicker wires, the stent, or a portion thereof, is coated with a thin radiopaque layer of material having high atomic weight, high density, sufficient surface area ànd sufficient thickness. With such a coating, the stent is sufficiently radiopaque to be seen with fluoroscopy, yet not so bright as to obstruct the radiopaque dye. This radiopaque layer covers at least a portion of the stent and can be formed from gold, tantalum, platinum, bismuth, iridium, zirconium, iodine, titanium, barium, silver, tin, alloys of these metals, or similar materials.
The radiopaque layer is thin, in one preferred embodiment it is about 1.0 to 50 microns thick. Because the layer is so thin, it is subject to scratching or flaking when the stent is being delivered intraluminally. Accordingly, it is an object of the invention to protect the stent and particularly the radiopaque layer with a more durable protective layer that is resistant to scratching and general mishandling.
Whenever two dissimilar metals are in direct contact, such as a stainless steel stent at least partly covered with a gold radiopaque layer, there is the potential to create the electrochemical reaction that causes galvanic corrosion. The 21 906q6 --3-- Docket No . ACS 40368 by-product of corrosion (i.e., rust) will not be biocompatible or blood compatible, may cause a toxic response, and may adversely affect adhesion of the radiopaque material.
Corrosion will occur if gold and another metal, like stainless steel, are in contact with the same bodily fluid (electrolyte).
If the gold coating has any pinholes or has a flaked or scratched-off surface, the underlying stainless steel will be exposed to the same fluid. Therefore, a galvanic reaction (i.e., a battery effect) will occur. The use of a single protective coating covering the entire surface prevents this reaction. This is especially pertinent when the radiopaque layer partially covers the stainless steel stent. The protective layer of the present invention also prevents galvanic corrosion so that the stent is biocompatible.
In one embodiment of the invention, a separate radiopaque layer can be eliminated by incorporating a radiopaque material, such as barium or titanium oxide, into the protective layer. In this embodiment, the stent is visible under fluoroscopy and it is protected by the protective layer, yet it will have a lower profile since it lacks a separate radiopaque layer.
The invention also includes the method of making the stent and of applying a radiopaque layer and a protective layer to it. The radiopaque coating can be applied by dipping, spraying, painting, electroplating, evaporation, plasma vapor deposition, cathodic arc deposition, sputtering, laser welding or fusing, resistance welding, and ion implantation. The protective layer can be applied by dip coating, spray coating, spin coating, plasma deposition, condensation, electro-chemically, electrostatically, electroplating, evaporation,plasma vapor deposition, cathodic arc deposition, sputtering, ion implantation, or use of a fluidized bed. The process for applying the radiopaque layer and the protective layer depends upon numerous factors which can include the type of material comprising the layer. These and other advantages of the invention will become more apparent from the following detailed description thereof and the accompanying exemplary drawings.
--4-- Docket No. ACS 40368 BRIEF DESCRIPTION OF THE DRAWINGS
FIGURE 1 is a perspective view depicting a stent having an open lattice structure and covered with both a radiopaque layer and a protective layer.
FIG. 2 is a cross-sectional view of the stent of FIG. 1 taken along lines 2-2, depicting the stent covered by a radiopaque layer and a protective layer over the radiopaque layer.
FIG. 3 is a cross-sectional view of one of the wires of the stent of FIG. 2 taken along lines 3-3, depicting the stent wire being coated with a radiopaque layer and a protective layer.
FIG. 4 is a perspective view of a stent having an open lattice structure and being partially covered by a radiopaque layer and completely covered by a protective layer.
FIG. 5 is a cross-sectional view taken along lines 5-5 of the stent of FIG. 4, depicting a partial radiopaque layer on the stent, covered by a protective layer.
FIG. 6 is a cross-sectional view taken along lines 6-6 of the stent of FIG. 5, depicting a straight portion of astent wire having a radiopaque layer covered by a protective layer.
FIG. 7 is a cross-sectional view of the stent of FIG.
5 depicting a stent having a protective layer with a radiopaque agent incorporated in the protective layer.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
A stent embodying the invention is intended for either temporary or permanent deployment in a body lumen such 21 906~6 -5-- Docket No. ACS 40368 as a coronary artery, carotid artery, vessels in the brain, aorta, peripheral arteries and veins, and the like. The stent also can be deployed in the urethra and other body lumens. The stent is used primarily to support the body lumen so that it remains patent and permits the uninterrupted flow of blood or other body fluids. It is important for purposes of delivery, deployment and post-operative diagnosis that the stent be both visible and remain biocompatible. A stent embodying the invention is visible due to a radiopaque layer and it remains biocompatible due its protective layer.
A stent that is made by known etching processes or laser cutting a metal tube, or by winding a metal wire(s), must be sufficiently thick to be radiopaque under X-ray or fluoroscopy ln vivo. Generally, current stent designs include an open lattice structure of interwoven wires or struts or coils that are made from stainless steel or other metals or metal alloys that are radiolucent due to a wire thickness or cross-section of about 0.076 mm (0.003 in.) or less. Unless the mètal or alloy used for making the stent has high atomic weight and density, it is difficult to visualize the stent ln vivo during catheter introduction into the vessel (artery, vein, urethra, etc.), stent deployment, and post-operative diagnosis. Another solution to increase radiopacity of the stent is to increase the strut or wire cross-section to approximately 0.102 mm (0.004 in.), however, this will result in a substantially more rigid stent having poor hemodynamics.
Therefore, coating the stent with a thin layer of material having high atomic weight, high density, sufficient thickness (15 microns or less), and large surface area will have an effect similar to that of thickening the stent. It will make the stent sufficiently radiopaque so that it can be seen, ln vivo but not so radiopaque to obstruct the view of radiopaque dye. The coating can be high atomic weight material such as gold, tantalum, platinum, bismuth, iridium, or the like. It also can be lower atomic weight material like zirconium, iodine, titanium, barium, silver, tin, or the like.
For the latter-type coatings, a thicker coating may be needed 21 9069~
-6-- Docket No. ACS 40368 to make the stent sufficiently radiopaque. In either case, a thin coating will allow the stent to remain thin and flexible while maintaining a low stent profile to minimize disruption of blood flow.
On the other hand, thickening the stent or changing the material used for making the stent to a more radiopaque material (i.e., tantalum, gold, etc.) may lead to poor stent performance. A thicker, high profile stent may result in areas of stagnation, turbulence, separation of flow, or other unacceptable fluid dynamics that can promote thrombogenesis.
A thicker stent has lower fatigue resistance due to its brittleness. A tantalum stent is brittle and cracks easily.
A gold stent will be prohibitively expensive and too ductile.
In the thickness range of less than 0.076 mm (0.003 in), a gold stent will not have sufficient strength to support the artery or body lumen. Both will be too radiopaque (stent made from all tàntalum or gold) and will obstruct the view of radiopaque dye when it flows through the lumen of the stent. Allowing visualization of the dye flowing through the stent lumen is important for diagnostics. Dye flowing through the stent lumen provides information to the clinician about restenosis, the size of artery, the size of the stent lumen during and after deployment, and the presence of dilation or other important parameters necessary for the care of the patient. This avoids the need for post-insertion and post-operative ultrasound detection procedures necessary to determine the diameters of the stent and vessel lumen. Therefore, a thin radiopaque coating is preferred over a stent made entirely from a highly radiopaque material.
Gold is the preferred radiopaque coating because of its high atomic weight and density, both of which contribute to its radiopacity. In addition, gold is a highly ductile metal and therefore, resists cracking when the stent is stressed during deployment or fatigue after deployment. A thin gold coating (less than 15 microns) is sufficient to absorb enough energy to be opaque when exposed to X-rays. Equivalent radiopacity cannot be achieved with a stent made from stainless 21 906q6 -7-- Docket No. ACS 40368 steel or the like unless the stent is at least twice the thickness. Studies have shown that a 2.0 to 3.0 micron gold coating (or other metal) on a 0.058 mm (0.0023 in.) thick 316L
stainless steel stent (l.e., where the diameter of the wires or 5 struts is 0. 058 mm (O. 0023 in.)) is sufficient to elevate the radiopacity to make it equivalent in radiopacity to a 0.102 mm (0.004 in.) thick 316L stent.
When dissimilar metals come in contact, such as the gold 'radiopaque coating on a stainless steel stent, the potential to initiate galvanic corrosion exists. This phenomenon occurs when two electrochemically dissimilar metals come in contact with each other. In addition, the radiopaque coating may be less biocompatible than the stent material and may induce thrombosis and stenosis after its deployment.
15 Furthèrmore, the radiopaque coating is prone to scratching and handling mishaps resulting in scratches, a chipped coating, flaking, or other defects. Surface irregularities on these coatings may act as loci for unwanted platelet adhesion or cell lysis.
In order to reduce galvanic corrosion and protect the coating, it is essential to coat the outermost surface of the stent (already coated with a radiopaque coating) with a protective coating. The protective coating provides a protective barrier against mishandling, prevents the 25 electrochemical reaction that causes galvanic corrosion, and is blood and tissue compatible. It is thin and flexible such that it wiil not crack during stent deployment. It will hide any flaws that are on the surface of the stent and prevent any extraordinary events from occurring. In addition, it has a 30 lower coefficient of friction than most stent materials. A
hydrogel layer also can be applied on the inside and/or outside surface of the stent by chemically bonding it to this protective coating. The hydrogel coating then can act as a buffer between the stent and vessel, minimizing vascular 35 injury.
In the preferred embodiment of the invention, as depicted in Figs. 1-2, the stent 10 is a generally cylindrical --8-- Docket No. ACS 40368 member having an elongated tubular body 11 with an outer surface 12 and an inner surface 13. When the stent 10 is made from a material that is substantially radiolucent, it is important to increase its radiopacity. In order to increase the visibility of the stent 10, a radiopaque layer 14 is applied to coat all of the stent 10, including the outer surface 12 and the inner surface 13. Typically, the stent 10 will be made from a plurality of intersecting struts or wires 15 that can be formed by known methods as described herein. In this embodiment, the radiopaque layer 14 is applied so that it covers all portions of the struts or the wires 15. As is shown in Fig. 3, the radiopaque layer 14 surrounds the strut 15 so that its radiopacity is ensured. It is preferred that the radiopaque layer 14 have a uniform thickness in the range of 1.0 to 50 microns and, more preferably, in the range of from 1.5 to 10 microns. If the radiopaque layer 14 is too thick, it also may result in the stent 10 being too bright under fluoroscopy and it may interfere with the expansion of the stent. Thus, the thickness of radiopaque layer should be uniform and in the preferred thickness ranges, depending upon such factors as the type of metal in the stent, where it will be implanted, the diameter of the struts 15, and the like.
In keeping with the preferred embodiment, as shown in Figs. 1-3, a protective layer 20 covers and surrounds the radiopaque layer 14 and protects it against scratches, flaking, and other mishandling. Generally, the radiopaque layer 14 will be formed from a relatively soft and malleable metal such as gold, and it is subject to scratching and flaking both before it delivered in the patient and after it is mounted on a catheter and delivered intraluminally. Thus, the protective layer 20 will provide a durable coating to protect the radiopaque layer.
As will almost always be the case, the stent 10 and the radiopaque layer 14 will be formed from dissimilar metals which may initiate the chemical reaction leading to galvanic corrosion. The protective layer 20 completely coats the --9-- Docket No. ACS 40368 radiopaque layer 14 thereby eliminating any likelihood of galvanic corrosion.
In another preferred embodiment, as seen in Figs. 4-6, the stent 10 is only partially coated by a partial radiopaque layer 30. Portions of the stent 10 are coated with the partial radiopaque layer 30, while the stent portion 31, which is curved, is not covered by a radiopaque layer. It is noted that the scale of the partial radiopaque layer 30 to the stent struts 33 and the protective layer 34 is somewhat out of proportion for ease of illustration. Typically, as has been demonstrated in experiments, the partial radiopaque layer 30 is applied to straight sections 32 of the struts 33 so that the stent can be expanded without distortion. Many commercial stents have curved sections and curved struts that will twist and deform if the radiopaque layer is applied to the curved section, since the radiopaque layer actually adds some rigidity to the stent. Thus, it is preferred that the partial radiopaque layer 30 be applied to the non-curved struts of the stent. In other stent configurations, it may not matter where the partial radiopaque layer 30 is applied on the stent 10.
The primary reason for the radiopaque layer is to enhance the visibility of the stent, but it should not interfere with stent expansion.
In the preferred embodiment shown in Figs. 4-6, the stent 10 is coated by the protective layer 34, which actually covers the stent portion 31 and the partial radiopaque layer 30. The protective layer 34 protects the partial radiopaque layer 30 as described above, and it eliminates the possibility of gàlvanic corrosion when the stent 10 and the partial radiopaque layer 30 are dissimilar metals.
In an alternative embodiment, the protective layer 34 covers only the partial radiopaque layer 30 and does not cover those portions of the stent 10 where there is no radiopaque coating. Thus, using FIG. 4 as an example, the partial radiopaque layer 30 is applied to straight sections 32 and the protective coating 34 is selectively applied to cover the partial radiopaque layer 30 only.
21 ~0696 --10-- Docket No. ACS 40368 The radiopaque coating can be made from solid metal (i.e., gold, silver, tin, tantalum, zirconium, platinum, or other metals), ceramic (Zirconia, alumina, zirconium nitrate, titanium nitrite, graphite, pyrolytic carbon, NEDOX, or other ceramics), metal/ceramic-filled particles dispersed in a polymer matrix, or other radiopaque material. The radiopaque coating can be coated anywhere on the stent. It can partially cover the stent (one or more bands, longitudinal continuous or discontinuous band, dots, outside surface only, inside surface only, etc.) or fully cover the stent.
In the preferred method of applying the radiopaque layer 14 or the partial radiopaque layer 30, a radiopaque coating can be applied by dipping, spraying, painting, electroplating, evaporation, plasma vapor deposition, cathodic arc deposition, sputtering, ion implantation, laser welding or fusion, resistance welding, or other methods. The thickness of the radiopaque coating generally is 50 microns or less. The coating can be applied on the inside and/or outside surface of the stent or it can fully encapsulate the stent strut(s).
For instance, a band of gold coating can be placed around the stent at the ends by first completely masking the stent with alkaline or acid-resistant mask material (i.e., the - material manufactured under the tradename "MICROSTOP" by Pyramid Chemical Company, polyesters, acrylic, wax, etc.). The type of mask material depends on what coating process is to be used. After the stent has been masked, the mask is removed preferentially from the stent surface, using a laser, sandblaster, or other appropriate method. Any pattern can be made by selectively removing mask material. The exposed surface (non-masked areas) then can be coated with radiopaque material by the above-described methods (i.e., electroplating).
Other masking techniques also are possible (i.e., physical, chemical, or mechanical). In addition, prefabricated gold markers also can be laser-fused or resistance-welded to the stent at any specific locations. Further details of applying a radiopaque layer to a stent are found in co-pending, U.S.
Serial No. 08/564,936.
21 9069~
--11-- Docket No. ACS 40368 In the preferred method of applying the protective layer 30,34, the biocompatible and blood-compatible protective layer can be polymeric, "PARYLAST", polymethylene, metallic, or ceramic. A polymeric layer (i.e., parylene, polycarbonate-urethane copolymer, silicone rubber, hydrogels, polyvinylalcohol, polyvinyl acetate, polycapralactone, urethanes, PHEMA-Acrylic, etc.) can be applied onto the radiopaque-coated stent by dip-coating, spray-coating, spin-coating, plasma deposition, condensation, electrochemically, electrostatically, or other suitable methods. "PARYLAST" is a preferred protective coating and is distributed by Advanced Surface Technology Corp. A
metallic coating (i.e., titanium and tantalum) can be applied by electroplating, evaporation, plasma-vapor deposition, cathodic-arc deposition, sputtering, ion implantation, electrostatically, electrochemically, a combination of the above, or the like. A ceramic coating (l.e., zirconium nitrite, pyrolytic carbon, graphite, a material sold under the tradename "NEDOX" by the General Magnaplate Corporation, and titanium nitrite) can be applied by the use of a fluidized bed, spraying, plasma-vapor deposition, evaporation, sputtering, electrochemically, electrostatically, a combination of the above, or the like. The thickness of the protective layer preferably is from .01 to 25 microns.
In an alternative preferred embodiment, as shown in Fig. 7, the stent 10 is at least partially covered by a protective coating 40 which is itself radiopaque. The protective coating 40 is loaded with radiopaque agents such as barium, titanium oxide, and the like. Further, multiple layers of the protective layer can be applied to the stent where the first layers are loaded with radiopaque agents while the outermost protective layer is not loaded with a radiopaque agent.
In another embodiment, not shown in the drawings, the protective layer is first applied to cover the stent and the radiopaque layer is applied to partially or completely cover the protective layer. In this embodiment, the radiopaque layer is scratch resistant and biocompatible.
- 21 906~
--12-- Docket No. ACS 40368 A protective layer has been described herein as a mechanical barrier which protects against mishandling, electrochemical reaction that causes galvanic corrosion, and against adverse blood and tissue response. It also is important that the protective layer form a conformal coating that will adhere to the stent surface. When there is no adhesion, any stretching and straining of the stent may lead to a rupture of the protective layer, resulting in folds at the strained areas (like elephant skin folds) which may lead to a penetration of blood and tissue causing an adverse response, or causing galvanic corrosion.
Thus, with respect to all of the protective layers disclosed herein, the process to improve adhesion between the protective coating and the substrate (the radiopaque layer) is desired. One such process is to deposit a thin intermediate layer or layers from the silane group or to plasma deposit a polymer from a gaseous organic such a methane, xylene or gases from the silane or titanate groups. A preferred method is to deposit "PARYLAST," a coating which incorporates the deposition of an intermediary followed by parylene C in the same processing chamber. In addition to an intermediary layer, improved adhesion can be attained by reducing the thickness of the protective coating. Thinner coatings tend to be more flexible, especially when the material has a glass transition temperature above room temperature. Thus, thinner coatings adhere better.
Thus, a preferred method is to deposit "PARYLAST,"
a parylene C coating, which incorporates the addition of an intermediary in the same process chamber.
Another method for improving the adhesion between the protective layer and the radiopaque layer is by acid treatment, sandblasting, or similar methods. These methods allow a mechanical interlocking between the substrate and the protective layer.
"PARYLAST" can be coated at different thicknesses that can vary from 0.013 mm to 0.0025 mm (.00005 in. to .0001 in.). It is preferred that the thickness of the "PARYLAST" be --13-- Docket No . ACS 40368 at least 0.0025 mm (0.0001 in.) in order to minimize the potential for pinhole formation, while maintaining the optimum flexibility (thicker coatings may be too rigid and affect stent expansion). The degree of texture on the substrate may vary from 1 to 250 micron average pore sizes. It is preferred that the substrate have a 1-6 micron average pore size. At larger pore sizes, the textured surface is retained on the coated surface after parylene C or a "PARYLAST" treatment.
After the protective layer is applied on the surface, other coatings that may be more blood compatible also can be applied. For example, coatings such as the one sold under the tradename "DUROFLO," manufactured by the Bentley Company, and the one sold under the tradename "PHOTOLINK HYDROGEL,"
manufactured by the BSI Corporation, and the one sold under the tradename "PHOTOLINK HEPARIN," also manufactured by the BSI
Corporation, or similar coatings, can enhance the blood compatibility of the stent.
While several particular forms of the invention have been illustrated and described, it will also be apparent that various modifications can be made without departing from the scope of the invention. Thus, it should be understood that various changes in form, and detail, and application of the present invention may be made without departing from the scope of this invention.
Claims (21)
1. A stent (10) for implanting in a body lumen, comprising:
an elongated tubular body (11) being substantially radiolucent;
a radiopaque layer (14) covering at least a portion of the elongated tubular body (11);
a protective layer (20) covering the elongated tubular body (11) and radiopaque layer (14) to reduce the likelihood of galvanic corrosion between the elongated tubular body and the radiopaque layer and to protect the layers from mishandling.
an elongated tubular body (11) being substantially radiolucent;
a radiopaque layer (14) covering at least a portion of the elongated tubular body (11);
a protective layer (20) covering the elongated tubular body (11) and radiopaque layer (14) to reduce the likelihood of galvanic corrosion between the elongated tubular body and the radiopaque layer and to protect the layers from mishandling.
2. The stent (10) of claim 1, wherein the elongated tubular body (11) is formed from a metallic material taken from the group of metallic materials including stainless steel, nickel-titanium, tantalum, and titanium.
3. The stent (10) of claim 1 or claim 2, wherein the elongated tubular body (11) has a wall surface made up of a plurality of struts (15) each having a diameter of less than about 0.102 mm (0.004 in.).
4. The stent (10) of any preceding claim, wherein the protective layer (20) has a thickness in the range of approximately .01 to 25 microns.
5. The stent (10) of claim 4, wherein the thickness of the protective layer (20) can vary in thickness on the elongated tubular body (11) from about .01 to 25 microns and on the radiopaque layer (14) from about 1.0 to 50 microns.
6. The stent (10) of any preceding claim, wherein the protective layer is biocompatible and blood compatible.
7. The stent (10) of any preceding claim, wherein the protective layer is formed from a polymeric, metallic or ceramic material.
8. The stent (10) of claim 7, wherein the protective layer (20) is formed from the polymeric material taken from the group of polymeric materials including "PARYLAST," parylene, polymethylene, polycarbonate-urethane copolymer, silicone rubber, hydrogels, polyvinyl alcohol, polyvinyl acetate, polycapralactone, urethanes, and PHEMA-Acrylic.
9. The stent (10) of claim 7, wherein the protective layer (20) is formed from the metallic material taken from the group of metallic materials including titanium, tantalum, and titanium-alloy.
10. The stent (10) of claim 7, wherein the protective layer (20) is formed from the ceramic material taken form the group of ceramic materials including zirconium nitrite, graphite, pyrolytic carbon, "NEDOX" and titanium nitrite.
11. The stent (10) of claim 1, wherein a second protective coating covers the protective coating (20) to provide further protection against the electrochemical reaction that causes galvanic corrosion.
12. A method for protecting a stent from the electrochemical reaction that causes galvanic corrosion, the method comprising:
providing an elongated tubular body (11) being substantially radiolucent;
applying a radiopaque layer (14) on at least a portion of the elongated tubular body; and applying a protective layer (20) on the elongated tubular body (11) and the radiopaque layer (14), the protective layer (20) covering all of the radiopaque layer and that portion of the elongated tubular body not covered by the radiopaque layer.
providing an elongated tubular body (11) being substantially radiolucent;
applying a radiopaque layer (14) on at least a portion of the elongated tubular body; and applying a protective layer (20) on the elongated tubular body (11) and the radiopaque layer (14), the protective layer (20) covering all of the radiopaque layer and that portion of the elongated tubular body not covered by the radiopaque layer.
13. The method of claim 12, wherein the method for applying the radiopaque layer (14) includes dipping, painting, electroplating, evaporation, plasma vapor deposition, cathodic arc deposition, sputtering, laser welding or fusion, resistance welding or ion implantation.
14. The method of claim 12 or claim 13, wherein the method for applying the protective layer (20) includes dipping, spraying, spin coating, plasma deposition, condensation, electrostatically, electrochemically, electroplating, evaporation, plasma vapor deposition, cathodic arc deposition, sputtering, ion implantation, or use of a fluidized bed.
15. A stent (10) for implanting in a body lumen, comprising:
an elongated tubular body (11) being substantially radiolucent; and a protective layer (20) covering the elongated tubular body (11), the protective layer having radiopaque means for increasing visibility under fluoroscopy, the protective layer (20) also protecting against the electrochemical reaction leading to galvanic corrosion.
an elongated tubular body (11) being substantially radiolucent; and a protective layer (20) covering the elongated tubular body (11), the protective layer having radiopaque means for increasing visibility under fluoroscopy, the protective layer (20) also protecting against the electrochemical reaction leading to galvanic corrosion.
16. The stent (10) of claim 15, wherein the protective layer (20) has a thickness in the range of .01 to 25 microns.
17. The stent (10) of claim 15, wherein the protective layer (20) is formed from a polymer, a metal, or a ceramic material.
18. The stent (10) of claim 17, wherein the radiopaque means includes loading the protective layer material with a radiopaque agent taken from the group of radiopaque agents including barium, titanium oxide, gold, or other metallic powders or particles.
19. The stent of any of claims 15-18, wherein the protective layer having radiopaque means for increasing visibility under fluoroscopy is covered by a second protective layer.
20. A stent (10) for implanting in a body lumen, comprising:
an elongated tubular body being substantially radiolucent;
a protective layer (20) covering the elongated tubular body; and a radiopaque layer (30) covering at least a portion of the protective layer so that the stent (10) is visible under fluoroscopic x-ray, the protective layer (34) reducing the likelihood of galvanic corrosion between the radiopaque layer and the elongated tubular body.
an elongated tubular body being substantially radiolucent;
a protective layer (20) covering the elongated tubular body; and a radiopaque layer (30) covering at least a portion of the protective layer so that the stent (10) is visible under fluoroscopic x-ray, the protective layer (34) reducing the likelihood of galvanic corrosion between the radiopaque layer and the elongated tubular body.
21. A stent (10) for implanting in a body lumen, comprising:
an elongated tubular body (11) being substantially radiolucent;
a radiopaque layer (30) covering at least a portion of the elongated tubular body; and a protective layer (34) covering at least a portion of the elongated tubular body (11) to reduce the likelihood of galvanic corrosion between the elongated tubular body and the radiopaque layer and wherein the protective layer is biocompatible and blood compatible.
an elongated tubular body (11) being substantially radiolucent;
a radiopaque layer (30) covering at least a portion of the elongated tubular body; and a protective layer (34) covering at least a portion of the elongated tubular body (11) to reduce the likelihood of galvanic corrosion between the elongated tubular body and the radiopaque layer and wherein the protective layer is biocompatible and blood compatible.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/701,708 US6174329B1 (en) | 1996-08-22 | 1996-08-22 | Protective coating for a stent with intermediate radiopaque coating |
US08/701,708 | 1996-08-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2190696A1 true CA2190696A1 (en) | 1998-02-22 |
Family
ID=24818355
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2190696A Abandoned CA2190696A1 (en) | 1996-08-22 | 1996-11-19 | Protective coating for a stent with intermediate radiopaque coating |
Country Status (7)
Country | Link |
---|---|
US (1) | US6174329B1 (en) |
EP (2) | EP1290984A3 (en) |
JP (1) | JPH1080492A (en) |
AU (1) | AU7177996A (en) |
CA (1) | CA2190696A1 (en) |
DE (1) | DE69627143T2 (en) |
NZ (1) | NZ299738A (en) |
Families Citing this family (309)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5735892A (en) * | 1993-08-18 | 1998-04-07 | W. L. Gore & Associates, Inc. | Intraluminal stent graft |
US6602281B1 (en) * | 1995-06-05 | 2003-08-05 | Avantec Vascular Corporation | Radially expansible vessel scaffold having beams and expansion joints |
US6174326B1 (en) | 1996-09-25 | 2001-01-16 | Terumo Kabushiki Kaisha | Radiopaque, antithrombogenic stent and method for its production |
US6340367B1 (en) * | 1997-08-01 | 2002-01-22 | Boston Scientific Scimed, Inc. | Radiopaque markers and methods of using the same |
US6174330B1 (en) * | 1997-08-01 | 2001-01-16 | Schneider (Usa) Inc | Bioabsorbable marker having radiopaque constituents |
US6156061A (en) * | 1997-08-29 | 2000-12-05 | Target Therapeutics, Inc. | Fast-detaching electrically insulated implant |
NO311781B1 (en) * | 1997-11-13 | 2002-01-28 | Medinol Ltd | Metal multilayer stents |
US7713297B2 (en) * | 1998-04-11 | 2010-05-11 | Boston Scientific Scimed, Inc. | Drug-releasing stent with ceramic-containing layer |
DE29810483U1 (en) * | 1998-06-12 | 1999-10-14 | Micro Science Medical Ag | Surface implantation or surface coating for stents or other implants |
US6387060B1 (en) * | 1998-06-17 | 2002-05-14 | Advanced Cardiovascular Systems, Inc. | Composite radiopaque intracorporeal product |
US6475234B1 (en) * | 1998-10-26 | 2002-11-05 | Medinol, Ltd. | Balloon expandable covered stents |
US7018401B1 (en) | 1999-02-01 | 2006-03-28 | Board Of Regents, The University Of Texas System | Woven intravascular devices and methods for making the same and apparatus for delivery of the same |
AU3709100A (en) * | 1999-02-26 | 2000-09-14 | Advanced Cardiovascular Systems Inc. | Composite super elastic/shape memory alloy and malleable alloy stent |
US6620192B1 (en) * | 1999-03-16 | 2003-09-16 | Advanced Cardiovascular Systems, Inc. | Multilayer stent |
US6730349B2 (en) * | 1999-04-19 | 2004-05-04 | Scimed Life Systems, Inc. | Mechanical and acoustical suspension coating of medical implants |
US6368658B1 (en) | 1999-04-19 | 2002-04-09 | Scimed Life Systems, Inc. | Coating medical devices using air suspension |
US6607598B2 (en) | 1999-04-19 | 2003-08-19 | Scimed Life Systems, Inc. | Device for protecting medical devices during a coating process |
US6585757B1 (en) * | 1999-09-15 | 2003-07-01 | Advanced Cardiovascular Systems, Inc. | Endovascular stent with radiopaque spine |
US6387123B1 (en) | 1999-10-13 | 2002-05-14 | Advanced Cardiovascular Systems, Inc. | Stent with radiopaque core |
DE19951477A1 (en) | 1999-10-26 | 2001-05-03 | Biotronik Mess & Therapieg | Stent |
US6554854B1 (en) * | 1999-12-10 | 2003-04-29 | Scimed Life Systems, Inc. | Process for laser joining dissimilar metals and endoluminal stent with radiopaque marker produced thereby |
US6355058B1 (en) * | 1999-12-30 | 2002-03-12 | Advanced Cardiovascular Systems, Inc. | Stent with radiopaque coating consisting of particles in a binder |
GB0003387D0 (en) * | 2000-02-14 | 2000-04-05 | Angiomed Ag | Stent matrix |
US6468301B1 (en) * | 2000-03-27 | 2002-10-22 | Aga Medical Corporation | Repositionable and recapturable vascular stent/graft |
DE10026540A1 (en) * | 2000-05-27 | 2001-11-29 | Gfe Met & Mat Gmbh | Object, especially implant |
US6540775B1 (en) | 2000-06-30 | 2003-04-01 | Cordis Corporation | Ultraflexible open cell stent |
GB0020491D0 (en) | 2000-08-18 | 2000-10-11 | Angiomed Ag | Stent with attached element and method of making such a stent |
US6649030B1 (en) * | 2000-08-31 | 2003-11-18 | Endovascular Technologies, Inc. | Physical vapor deposition of radiopaque markings on a graft |
DE10044559A1 (en) * | 2000-09-08 | 2002-04-04 | Karlsruhe Forschzent | Coated implant |
US6669722B2 (en) * | 2000-09-22 | 2003-12-30 | Cordis Corporation | Stent with optimal strength and radiopacity characteristics |
US8167785B2 (en) | 2000-10-12 | 2012-05-01 | Coloplast A/S | Urethral support system |
GB0025068D0 (en) | 2000-10-12 | 2000-11-29 | Browning Healthcare Ltd | Apparatus and method for treating female urinary incontinence |
US20060205995A1 (en) | 2000-10-12 | 2006-09-14 | Gyne Ideas Limited | Apparatus and method for treating female urinary incontinence |
US6656211B1 (en) * | 2000-10-26 | 2003-12-02 | Scimed Life Systems, Inc. | Stent delivery system with improved tracking |
US6758859B1 (en) * | 2000-10-30 | 2004-07-06 | Kenny L. Dang | Increased drug-loading and reduced stress drug delivery device |
US7776310B2 (en) | 2000-11-16 | 2010-08-17 | Microspherix Llc | Flexible and/or elastic brachytherapy seed or strand |
US7077837B2 (en) * | 2000-11-20 | 2006-07-18 | Implant Sciences Corporation | Multi-layered radiopaque coating on intravascular devices |
US6398806B1 (en) | 2000-12-26 | 2002-06-04 | Scimed Life Systems, Inc. | Monolayer modification to gold coated stents to reduce adsorption of protein |
US6569194B1 (en) * | 2000-12-28 | 2003-05-27 | Advanced Cardiovascular Systems, Inc. | Thermoelastic and superelastic Ni-Ti-W alloy |
US20020095205A1 (en) * | 2001-01-12 | 2002-07-18 | Edwin Tarun J. | Encapsulated radiopaque markers |
US6790227B2 (en) * | 2001-03-01 | 2004-09-14 | Cordis Corporation | Flexible stent |
US6998060B2 (en) | 2001-03-01 | 2006-02-14 | Cordis Corporation | Flexible stent and method of manufacture |
US20030069630A1 (en) * | 2001-03-02 | 2003-04-10 | Robert Burgermeister | Stent with radiopaque markers incorporated thereon |
AU784552B2 (en) * | 2001-03-02 | 2006-05-04 | Cardinal Health 529, Llc | Flexible stent |
US6733525B2 (en) | 2001-03-23 | 2004-05-11 | Edwards Lifesciences Corporation | Rolled minimally-invasive heart valves and methods of use |
US20020138136A1 (en) * | 2001-03-23 | 2002-09-26 | Scimed Life Systems, Inc. | Medical device having radio-opacification and barrier layers |
GB0108088D0 (en) | 2001-03-30 | 2001-05-23 | Browning Healthcare Ltd | Surgical implant |
US6695920B1 (en) * | 2001-06-27 | 2004-02-24 | Advanced Cardiovascular Systems, Inc. | Mandrel for supporting a stent and a method of using the mandrel to coat a stent |
WO2003002243A2 (en) | 2001-06-27 | 2003-01-09 | Remon Medical Technologies Ltd. | Method and device for electrochemical formation of therapeutic species in vivo |
WO2003009773A2 (en) * | 2001-07-26 | 2003-02-06 | Alveolus Inc. | Removable stent and method of using the same |
US6926733B2 (en) * | 2001-08-02 | 2005-08-09 | Boston Scientific Scimed, Inc. | Method for enhancing sheet or tubing metal stent radiopacity |
US20060004437A1 (en) * | 2001-08-29 | 2006-01-05 | Swaminathan Jayaraman | Structurally variable stents |
US6908480B2 (en) | 2001-08-29 | 2005-06-21 | Swaminathan Jayaraman | Structurally variable stents |
US7776379B2 (en) * | 2001-09-19 | 2010-08-17 | Medlogics Device Corporation | Metallic structures incorporating bioactive materials and methods for creating the same |
US20030060873A1 (en) * | 2001-09-19 | 2003-03-27 | Nanomedical Technologies, Inc. | Metallic structures incorporating bioactive materials and methods for creating the same |
US20030060872A1 (en) * | 2001-09-26 | 2003-03-27 | Gary Gomringer | Stent with radiopaque characteristics |
US20030077310A1 (en) * | 2001-10-22 | 2003-04-24 | Chandrashekhar Pathak | Stent coatings containing HMG-CoA reductase inhibitors |
US20030088195A1 (en) * | 2001-11-02 | 2003-05-08 | Vardi Gil M | Guidewire having measurement indicia |
US6939376B2 (en) * | 2001-11-05 | 2005-09-06 | Sun Biomedical, Ltd. | Drug-delivery endovascular stent and method for treating restenosis |
US7682387B2 (en) * | 2002-04-24 | 2010-03-23 | Biosensors International Group, Ltd. | Drug-delivery endovascular stent and method for treating restenosis |
GB0127033D0 (en) * | 2001-11-09 | 2002-01-02 | Biocompatibles Ltd | Stent manufacture |
US6981985B2 (en) * | 2002-01-22 | 2006-01-03 | Boston Scientific Scimed, Inc. | Stent bumper struts |
US20030153971A1 (en) * | 2002-02-14 | 2003-08-14 | Chandru Chandrasekaran | Metal reinforced biodegradable intraluminal stents |
US20030165614A1 (en) * | 2002-03-01 | 2003-09-04 | Henrik Hansen | Coating a medical implant using a pan coater |
US20040024450A1 (en) * | 2002-04-24 | 2004-02-05 | Sun Biomedical, Ltd. | Drug-delivery endovascular stent and method for treating restenosis |
US7083822B2 (en) * | 2002-04-26 | 2006-08-01 | Medtronic Vascular, Inc. | Overlapping coated stents |
US7343659B2 (en) * | 2002-07-10 | 2008-03-18 | Boston Scientific Scimed, Inc. | Method of making a medical device |
US20050154449A1 (en) * | 2002-07-31 | 2005-07-14 | David Elmaleh | Non-biodegradable drug-eluting sleeves for intravascular devices |
US20040054399A1 (en) * | 2002-09-17 | 2004-03-18 | Roth Noah M. | Anti-galvanic stent coating |
DE60226236T3 (en) * | 2002-09-20 | 2011-12-15 | Abbott Laboratories Vascular Enterprises Ltd. | A rough-surfaced stent and its manufacturing process |
US20060100695A1 (en) * | 2002-09-27 | 2006-05-11 | Peacock James C Iii | Implantable stent with modified ends |
US7135038B1 (en) * | 2002-09-30 | 2006-11-14 | Advanced Cardiovascular Systems, Inc. | Drug eluting stent |
US7404979B1 (en) | 2002-09-30 | 2008-07-29 | Advanced Cardiovascular Systems Inc. | Spin coating apparatus and a method for coating implantable devices |
US8337937B2 (en) * | 2002-09-30 | 2012-12-25 | Abbott Cardiovascular Systems Inc. | Stent spin coating method |
US6638301B1 (en) * | 2002-10-02 | 2003-10-28 | Scimed Life Systems, Inc. | Medical device with radiopacity |
US20040093056A1 (en) * | 2002-10-26 | 2004-05-13 | Johnson Lianw M. | Medical appliance delivery apparatus and method of use |
US7959671B2 (en) * | 2002-11-05 | 2011-06-14 | Merit Medical Systems, Inc. | Differential covering and coating methods |
US7637942B2 (en) * | 2002-11-05 | 2009-12-29 | Merit Medical Systems, Inc. | Coated stent with geometry determinated functionality and method of making the same |
US7527644B2 (en) * | 2002-11-05 | 2009-05-05 | Alveolus Inc. | Stent with geometry determinated functionality and method of making the same |
US7875068B2 (en) | 2002-11-05 | 2011-01-25 | Merit Medical Systems, Inc. | Removable biliary stent |
WO2004043507A1 (en) * | 2002-11-07 | 2004-05-27 | Carbon Medical Technologies, Inc. | Biocompatible medical device coatings |
US6982004B1 (en) * | 2002-11-26 | 2006-01-03 | Advanced Cardiovascular Systems, Inc. | Electrostatic loading of drugs on implantable medical devices |
US7074276B1 (en) * | 2002-12-12 | 2006-07-11 | Advanced Cardiovascular Systems, Inc. | Clamp mandrel fixture and a method of using the same to minimize coating defects |
US8066854B2 (en) * | 2002-12-18 | 2011-11-29 | Metascape Llc | Antimicrobial coating methods |
US20040143317A1 (en) * | 2003-01-17 | 2004-07-22 | Stinson Jonathan S. | Medical devices |
US7172624B2 (en) * | 2003-02-06 | 2007-02-06 | Boston Scientific Scimed, Inc. | Medical device with magnetic resonance visibility enhancing structure |
US7399296B2 (en) * | 2003-02-26 | 2008-07-15 | Medtronic Vascular, Inc. | Catheter having highly radiopaque embedded segment |
GB0307082D0 (en) | 2003-03-27 | 2003-04-30 | Gyne Ideas Ltd | Drug delivery device and method |
US20050283042A1 (en) * | 2003-03-28 | 2005-12-22 | Steve Meyer | Cardiac harness having radiopaque coating and method of use |
US7637934B2 (en) * | 2003-03-31 | 2009-12-29 | Merit Medical Systems, Inc. | Medical appliance optical delivery and deployment apparatus and method |
DE10317241A1 (en) * | 2003-04-10 | 2004-10-28 | Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin | stent |
US20040236399A1 (en) * | 2003-04-22 | 2004-11-25 | Medtronic Vascular, Inc. | Stent with improved surface adhesion |
DE202004009059U1 (en) * | 2003-05-16 | 2004-09-16 | Blue Membranes Gmbh | Substrates coated with carbon-based material |
US20040254637A1 (en) * | 2003-06-16 | 2004-12-16 | Endotex Interventional Systems, Inc. | Sleeve stent marker |
US7491227B2 (en) * | 2003-06-16 | 2009-02-17 | Boston Scientific Scimed, Inc. | Coiled-sheet stent with flexible mesh design |
US7335185B2 (en) | 2003-07-18 | 2008-02-26 | Boston Scientific Scimed, Inc. | Protective coatings for medical devices |
US7920906B2 (en) | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US7004176B2 (en) * | 2003-10-17 | 2006-02-28 | Edwards Lifesciences Ag | Heart valve leaflet locator |
US7208172B2 (en) * | 2003-11-03 | 2007-04-24 | Medlogics Device Corporation | Metallic composite coating for delivery of therapeutic agents from the surface of implantable devices |
US9247900B2 (en) | 2004-07-13 | 2016-02-02 | Dexcom, Inc. | Analyte sensor |
US20050119723A1 (en) * | 2003-11-28 | 2005-06-02 | Medlogics Device Corporation | Medical device with porous surface containing bioerodable bioactive composites and related methods |
US20060085062A1 (en) * | 2003-11-28 | 2006-04-20 | Medlogics Device Corporation | Implantable stent with endothelialization factor |
DE10361942A1 (en) * | 2003-12-24 | 2005-07-21 | Restate Patent Ag | Radioopaque marker for medical implants |
US8002822B2 (en) * | 2004-01-22 | 2011-08-23 | Isoflux, Inc. | Radiopaque coating for biomedical devices |
JP2007518528A (en) * | 2004-01-22 | 2007-07-12 | イソフラックス・インコーポレイテッド | Radiopaque coatings for biomedical devices |
US20050288773A1 (en) * | 2004-01-22 | 2005-12-29 | Glocker David A | Radiopaque coating for biomedical devices |
US20070106374A1 (en) * | 2004-01-22 | 2007-05-10 | Isoflux, Inc. | Radiopaque coating for biomedical devices |
WO2005076973A2 (en) * | 2004-02-05 | 2005-08-25 | Children's Medical Center Corporation | Transcatheter delivery of a replacement heart valve |
US7243408B2 (en) * | 2004-02-09 | 2007-07-17 | Boston Scientific Scimed, Inc. | Process method for attaching radio opaque markers to shape memory stent |
US20050180919A1 (en) * | 2004-02-12 | 2005-08-18 | Eugene Tedeschi | Stent with radiopaque and encapsulant coatings |
TWI434676B (en) | 2004-03-19 | 2014-04-21 | Merck Sharp & Dohme | X-ray visible drug delivery device |
EP1791667A4 (en) * | 2004-03-23 | 2011-08-17 | Isoflux Inc | Radiopaque coating for biomedical devices |
US20050220853A1 (en) * | 2004-04-02 | 2005-10-06 | Kinh-Luan Dao | Controlled delivery of therapeutic agents from medical articles |
US7758892B1 (en) * | 2004-05-20 | 2010-07-20 | Boston Scientific Scimed, Inc. | Medical devices having multiple layers |
GB0411360D0 (en) | 2004-05-21 | 2004-06-23 | Mpathy Medical Devices Ltd | Implant |
US8894824B2 (en) * | 2004-06-28 | 2014-11-25 | Isoflux, Inc. | Porous coatings for biomedical implants |
US8170803B2 (en) | 2004-07-13 | 2012-05-01 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20070045902A1 (en) | 2004-07-13 | 2007-03-01 | Brauker James H | Analyte sensor |
CA2573329A1 (en) * | 2004-07-13 | 2006-02-16 | Isoflux, Inc. | Porous coatings on electrodes for biomedical implants |
US20060025848A1 (en) * | 2004-07-29 | 2006-02-02 | Jan Weber | Medical device having a coating layer with structural elements therein and method of making the same |
US8980300B2 (en) | 2004-08-05 | 2015-03-17 | Advanced Cardiovascular Systems, Inc. | Plasticizers for coating compositions |
US8119153B2 (en) * | 2004-08-26 | 2012-02-21 | Boston Scientific Scimed, Inc. | Stents with drug eluting coatings |
US7919112B2 (en) * | 2004-08-26 | 2011-04-05 | Pathak Holdings, Llc | Implantable tissue compositions and method |
US8366762B2 (en) * | 2004-08-31 | 2013-02-05 | Advanced Cardiovascular Systems, Inc. | Method of making a medical device with regioselective structure-property distribution |
US9468704B2 (en) | 2004-09-07 | 2016-10-18 | Biotronik Vi Patent Ag | Implant made of a biodegradable magnesium alloy |
US7901451B2 (en) * | 2004-09-24 | 2011-03-08 | Biosensors International Group, Ltd. | Drug-delivery endovascular stent and method for treating restenosis |
US20060083770A1 (en) * | 2004-10-15 | 2006-04-20 | Specialty Coating Systems, Inc. | Medical devices and methods of preparation and use |
US7455688B2 (en) * | 2004-11-12 | 2008-11-25 | Con Interventional Systems, Inc. | Ostial stent |
US20060127443A1 (en) * | 2004-12-09 | 2006-06-15 | Helmus Michael N | Medical devices having vapor deposited nanoporous coatings for controlled therapeutic agent delivery |
KR100511618B1 (en) * | 2005-01-17 | 2005-08-31 | 이경범 | Multi-layer coating of drug release controllable coronary stent and method for manufacturing the same |
US8057543B2 (en) * | 2005-01-28 | 2011-11-15 | Greatbatch Ltd. | Stent coating for eluting medication |
US20060201601A1 (en) * | 2005-03-03 | 2006-09-14 | Icon Interventional Systems, Inc. | Flexible markers |
EP1698907A1 (en) * | 2005-03-04 | 2006-09-06 | Cardiatis Société Anonyme | Interventional medical device for use in MRI |
US20070213810A1 (en) * | 2005-03-14 | 2007-09-13 | Richard Newhauser | Segmented endoprosthesis |
US7837726B2 (en) * | 2005-03-14 | 2010-11-23 | Abbott Laboratories | Visible endoprosthesis |
US20070255094A1 (en) * | 2005-03-14 | 2007-11-01 | Oepen Randolf V | Crack/fatigue resistant endoprosthesis |
US9381279B2 (en) * | 2005-03-24 | 2016-07-05 | Abbott Cardiovascular Systems Inc. | Implantable devices formed on non-fouling methacrylate or acrylate polymers |
US7700659B2 (en) * | 2005-03-24 | 2010-04-20 | Advanced Cardiovascular Systems, Inc. | Implantable devices formed of non-fouling methacrylate or acrylate polymers |
US7955639B2 (en) * | 2005-03-31 | 2011-06-07 | Innovational Holdings, Llc. | System and method for loading a beneficial agent into a medical device |
CA2604419C (en) * | 2005-04-05 | 2015-03-24 | Elixir Medical Corporation | Degradable implantable medical devices |
US8628565B2 (en) | 2005-04-13 | 2014-01-14 | Abbott Cardiovascular Systems Inc. | Intravascular stent |
US20060276910A1 (en) * | 2005-06-01 | 2006-12-07 | Jan Weber | Endoprostheses |
US7622070B2 (en) * | 2005-06-20 | 2009-11-24 | Advanced Cardiovascular Systems, Inc. | Method of manufacturing an implantable polymeric medical device |
US7823533B2 (en) * | 2005-06-30 | 2010-11-02 | Advanced Cardiovascular Systems, Inc. | Stent fixture and method for reducing coating defects |
US20070038176A1 (en) * | 2005-07-05 | 2007-02-15 | Jan Weber | Medical devices with machined layers for controlled communications with underlying regions |
US7735449B1 (en) | 2005-07-28 | 2010-06-15 | Advanced Cardiovascular Systems, Inc. | Stent fixture having rounded support structures and method for use thereof |
US7867176B2 (en) * | 2005-12-27 | 2011-01-11 | Cordis Corporation | Variable stiffness guidewire |
US20070148390A1 (en) * | 2005-12-27 | 2007-06-28 | Specialty Coating Systems, Inc. | Fluorinated coatings |
US20070154466A1 (en) * | 2005-12-30 | 2007-07-05 | Jan Weber | Internal medical devices containing peroxide-converting catalysts |
US20070156230A1 (en) | 2006-01-04 | 2007-07-05 | Dugan Stephen R | Stents with radiopaque markers |
US8840660B2 (en) * | 2006-01-05 | 2014-09-23 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US20070173925A1 (en) * | 2006-01-25 | 2007-07-26 | Cornova, Inc. | Flexible expandable stent |
US9422622B2 (en) | 2006-01-30 | 2016-08-23 | Surfatek Llc | Flexible conductive single wire |
US20100057179A1 (en) * | 2006-01-30 | 2010-03-04 | Chameleon Scientific Corporation | Conductive metal thin coatings for implantable medical sensing devices |
US8089029B2 (en) * | 2006-02-01 | 2012-01-03 | Boston Scientific Scimed, Inc. | Bioabsorbable metal medical device and method of manufacture |
US20100010622A1 (en) * | 2006-03-13 | 2010-01-14 | Abbott Laboratories | Hybrid segmented endoprosthesis |
US20070224244A1 (en) * | 2006-03-22 | 2007-09-27 | Jan Weber | Corrosion resistant coatings for biodegradable metallic implants |
US20070224235A1 (en) * | 2006-03-24 | 2007-09-27 | Barron Tenney | Medical devices having nanoporous coatings for controlled therapeutic agent delivery |
US8187620B2 (en) * | 2006-03-27 | 2012-05-29 | Boston Scientific Scimed, Inc. | Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents |
US7785317B2 (en) | 2006-03-29 | 2010-08-31 | Codman & Shurtleff, Inc. | Joined metal tubing and method of manufacture |
US8048150B2 (en) * | 2006-04-12 | 2011-11-01 | Boston Scientific Scimed, Inc. | Endoprosthesis having a fiber meshwork disposed thereon |
US7955383B2 (en) * | 2006-04-25 | 2011-06-07 | Medtronics Vascular, Inc. | Laminated implantable medical device having a metallic coating |
US20070259116A1 (en) * | 2006-05-02 | 2007-11-08 | Boston Scientific Scimed, Inc. | Partially coated workpiece and method of making same |
US8069814B2 (en) | 2006-05-04 | 2011-12-06 | Advanced Cardiovascular Systems, Inc. | Stent support devices |
US7985441B1 (en) | 2006-05-04 | 2011-07-26 | Yiwen Tang | Purification of polymers for coating applications |
JP2009536074A (en) * | 2006-05-05 | 2009-10-08 | チルドレンズ・メディカル・センター・コーポレイション | Transcatheter heart valve |
US20070264303A1 (en) * | 2006-05-12 | 2007-11-15 | Liliana Atanasoska | Coating for medical devices comprising an inorganic or ceramic oxide and a therapeutic agent |
GB0609841D0 (en) | 2006-05-17 | 2006-06-28 | Angiomed Ag | Bend-capable tubular prosthesis |
GB0609911D0 (en) | 2006-05-18 | 2006-06-28 | Angiomed Ag | Bend-capable stent prosthesis |
US8752268B2 (en) * | 2006-05-26 | 2014-06-17 | Abbott Cardiovascular Systems Inc. | Method of making stents with radiopaque markers |
US8690938B2 (en) * | 2006-05-26 | 2014-04-08 | DePuy Synthes Products, LLC | Occlusion device combination of stent and mesh with diamond-shaped porosity |
US8118859B2 (en) * | 2006-05-26 | 2012-02-21 | Codman & Shurtleff, Inc. | Occlusion device combination of stent and mesh having offset parallelogram porosity |
US7670353B2 (en) * | 2006-06-12 | 2010-03-02 | Codman & Shurtleff, Inc. | Modified headpiece for hydraulic coil deployment system |
US7766935B2 (en) * | 2006-06-12 | 2010-08-03 | Codman & Shurtleff, Inc. | Modified headpiece for hydraulic coil deployment system |
US8585732B2 (en) * | 2006-06-14 | 2013-11-19 | DePuy Synthes Products, LLC | Retrieval device with sidewall grippers |
US8815275B2 (en) | 2006-06-28 | 2014-08-26 | Boston Scientific Scimed, Inc. | Coatings for medical devices comprising a therapeutic agent and a metallic material |
CA2655793A1 (en) * | 2006-06-29 | 2008-01-03 | Boston Scientific Limited | Medical devices with selective coating |
US9265866B2 (en) * | 2006-08-01 | 2016-02-23 | Abbott Cardiovascular Systems Inc. | Composite polymeric and metallic stent with radiopacity |
EP2054537A2 (en) | 2006-08-02 | 2009-05-06 | Boston Scientific Scimed, Inc. | Endoprosthesis with three-dimensional disintegration control |
CN101588826A (en) * | 2006-08-02 | 2009-11-25 | 英孚拉玛特公司 | Lumen-supporting devices and methods of making and using |
DE102006038233A1 (en) * | 2006-08-07 | 2008-02-14 | Biotronik Vi Patent Ag | Marker composite for medical implants |
DE102006038238A1 (en) * | 2006-08-07 | 2008-02-14 | Biotronik Vi Patent Ag | X-ray marker for medical implants made of a biocorrodible metallic material |
DE102006038232A1 (en) * | 2006-08-07 | 2008-02-14 | Biotronik Vi Patent Ag | Endoprosthesis and method for producing such |
GB0616729D0 (en) * | 2006-08-23 | 2006-10-04 | Angiomed Ag | Method of welding a component to a shape memory alloy workpiece |
EP2077797A4 (en) * | 2006-08-28 | 2010-07-21 | Cornova Inc | Implantable devices and methods of forming the same |
US20080177371A1 (en) * | 2006-08-28 | 2008-07-24 | Cornova, Inc. | Implantable devices and methods of forming the same |
GB0616999D0 (en) * | 2006-08-29 | 2006-10-04 | Angiomed Ag | Annular mesh |
US8500793B2 (en) * | 2006-09-07 | 2013-08-06 | C. R. Bard, Inc. | Helical implant having different ends |
CA2662808A1 (en) | 2006-09-14 | 2008-03-20 | Boston Scientific Limited | Medical devices with drug-eluting coating |
EP2210625B8 (en) | 2006-09-15 | 2012-02-29 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis with biostable inorganic layers |
EP2081616B1 (en) * | 2006-09-15 | 2017-11-01 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
JP2010503494A (en) * | 2006-09-15 | 2010-02-04 | ボストン サイエンティフィック リミテッド | Biodegradable endoprosthesis and method for producing the same |
CA2663220A1 (en) * | 2006-09-15 | 2008-03-20 | Boston Scientific Limited | Medical devices and methods of making the same |
US8002821B2 (en) * | 2006-09-18 | 2011-08-23 | Boston Scientific Scimed, Inc. | Bioerodible metallic ENDOPROSTHESES |
CA2663717A1 (en) * | 2006-09-18 | 2008-03-27 | Boston Scientific Limited | Controlling biodegradation of a medical instrument |
US20080069858A1 (en) * | 2006-09-20 | 2008-03-20 | Boston Scientific Scimed, Inc. | Medical devices having biodegradable polymeric regions with overlying hard, thin layers |
EP2084310A1 (en) * | 2006-10-05 | 2009-08-05 | Boston Scientific Limited | Polymer-free coatings for medical devices formed by plasma electrolytic deposition |
US20080097591A1 (en) | 2006-10-20 | 2008-04-24 | Biosensors International Group | Drug-delivery endovascular stent and method of use |
US8067055B2 (en) * | 2006-10-20 | 2011-11-29 | Biosensors International Group, Ltd. | Drug-delivery endovascular stent and method of use |
EP3150177B1 (en) | 2006-10-22 | 2021-06-02 | Idev Technologies, Inc. | Methods for securing strand ends and the resulting devices |
US20080103584A1 (en) * | 2006-10-25 | 2008-05-01 | Biosensors International Group | Temporal Intraluminal Stent, Methods of Making and Using |
US7981150B2 (en) | 2006-11-09 | 2011-07-19 | Boston Scientific Scimed, Inc. | Endoprosthesis with coatings |
GB0622465D0 (en) | 2006-11-10 | 2006-12-20 | Angiomed Ag | Stent |
GB0624419D0 (en) * | 2006-12-06 | 2007-01-17 | Angiomed Ag | Stenting ring with marker |
ES2506144T3 (en) * | 2006-12-28 | 2014-10-13 | Boston Scientific Limited | Bioerodible endoprosthesis and their manufacturing procedure |
US8114466B2 (en) * | 2007-01-03 | 2012-02-14 | Boston Scientific Scimed, Inc. | Methods of applying coating to the inside surface of a stent |
US20080166526A1 (en) * | 2007-01-08 | 2008-07-10 | Monk Russell A | Formed panel structure |
GB0703379D0 (en) * | 2007-02-21 | 2007-03-28 | Angiomed Ag | Stent with radiopaque marker |
US8070797B2 (en) | 2007-03-01 | 2011-12-06 | Boston Scientific Scimed, Inc. | Medical device with a porous surface for delivery of a therapeutic agent |
US8431149B2 (en) | 2007-03-01 | 2013-04-30 | Boston Scientific Scimed, Inc. | Coated medical devices for abluminal drug delivery |
GB0706499D0 (en) | 2007-04-03 | 2007-05-09 | Angiomed Ag | Bendable stent |
US8067054B2 (en) | 2007-04-05 | 2011-11-29 | Boston Scientific Scimed, Inc. | Stents with ceramic drug reservoir layer and methods of making and using the same |
US8409270B2 (en) | 2007-04-16 | 2013-04-02 | Boston Scientific Scimed, Inc. | Radiopaque compositions, stents and methods of preparation |
ITRM20070245A1 (en) * | 2007-04-30 | 2008-11-01 | Alma Mater Studiorum Uni Di Bologna | RADIOOPAC ORGANIC INORGANIC HYBRID THAT INCLUDES AN INORGANIC BONE AND POLYMER |
US8500786B2 (en) * | 2007-05-15 | 2013-08-06 | Abbott Laboratories | Radiopaque markers comprising binary alloys of titanium |
US8500787B2 (en) * | 2007-05-15 | 2013-08-06 | Abbott Laboratories | Radiopaque markers and medical devices comprising binary alloys of titanium |
US7976915B2 (en) * | 2007-05-23 | 2011-07-12 | Boston Scientific Scimed, Inc. | Endoprosthesis with select ceramic morphology |
US7942926B2 (en) * | 2007-07-11 | 2011-05-17 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US8002823B2 (en) * | 2007-07-11 | 2011-08-23 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
EP2187988B1 (en) | 2007-07-19 | 2013-08-21 | Boston Scientific Limited | Endoprosthesis having a non-fouling surface |
US7931683B2 (en) | 2007-07-27 | 2011-04-26 | Boston Scientific Scimed, Inc. | Articles having ceramic coated surfaces |
US8815273B2 (en) * | 2007-07-27 | 2014-08-26 | Boston Scientific Scimed, Inc. | Drug eluting medical devices having porous layers |
WO2009018340A2 (en) * | 2007-07-31 | 2009-02-05 | Boston Scientific Scimed, Inc. | Medical device coating by laser cladding |
EP2185103B1 (en) * | 2007-08-03 | 2014-02-12 | Boston Scientific Scimed, Inc. | Coating for medical device having increased surface area |
GB0717481D0 (en) | 2007-09-07 | 2007-10-17 | Angiomed Ag | Self-expansible stent with radiopaque markers |
US8052745B2 (en) * | 2007-09-13 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis |
KR100930167B1 (en) * | 2007-09-19 | 2009-12-07 | 삼성전기주식회사 | Ultra wide angle optical system |
CA2699685A1 (en) * | 2007-09-25 | 2009-04-02 | Surmodics, Inc. | Durable swellable hydrogel matrix and methods |
US8142490B2 (en) * | 2007-10-24 | 2012-03-27 | Cordis Corporation | Stent segments axially connected by thin film |
US8216632B2 (en) | 2007-11-02 | 2012-07-10 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US20090118809A1 (en) * | 2007-11-02 | 2009-05-07 | Torsten Scheuermann | Endoprosthesis with porous reservoir and non-polymer diffusion layer |
US20090118813A1 (en) * | 2007-11-02 | 2009-05-07 | Torsten Scheuermann | Nano-patterned implant surfaces |
US7938855B2 (en) | 2007-11-02 | 2011-05-10 | Boston Scientific Scimed, Inc. | Deformable underlayer for stent |
US8029554B2 (en) * | 2007-11-02 | 2011-10-04 | Boston Scientific Scimed, Inc. | Stent with embedded material |
US20090143855A1 (en) * | 2007-11-29 | 2009-06-04 | Boston Scientific Scimed, Inc. | Medical Device Including Drug-Loaded Fibers |
US20100008970A1 (en) * | 2007-12-14 | 2010-01-14 | Boston Scientific Scimed, Inc. | Drug-Eluting Endoprosthesis |
US9241792B2 (en) * | 2008-02-29 | 2016-01-26 | Edwards Lifesciences Corporation | Two-step heart valve implantation |
WO2009131911A2 (en) | 2008-04-22 | 2009-10-29 | Boston Scientific Scimed, Inc. | Medical devices having a coating of inorganic material |
WO2009132176A2 (en) | 2008-04-24 | 2009-10-29 | Boston Scientific Scimed, Inc. | Medical devices having inorganic particle layers |
EP2276518A2 (en) * | 2008-05-01 | 2011-01-26 | Boston Scientific Scimed, Inc. | Drug-loaded medical devices and methods for manufacturing drug-loaded medical devices |
US7998192B2 (en) | 2008-05-09 | 2011-08-16 | Boston Scientific Scimed, Inc. | Endoprostheses |
US8236046B2 (en) | 2008-06-10 | 2012-08-07 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
EP2303350A2 (en) | 2008-06-18 | 2011-04-06 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
EP2293838B1 (en) | 2008-07-01 | 2012-08-08 | Endologix, Inc. | Catheter system |
US20100004733A1 (en) * | 2008-07-02 | 2010-01-07 | Boston Scientific Scimed, Inc. | Implants Including Fractal Structures |
DE102008040640A1 (en) * | 2008-07-23 | 2010-01-28 | Biotronik Vi Patent Ag | Endoprosthesis and method of making the same |
US7985252B2 (en) * | 2008-07-30 | 2011-07-26 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US9408649B2 (en) * | 2008-09-11 | 2016-08-09 | Innovasis, Inc. | Radiolucent screw with radiopaque marker |
DE602008006079D1 (en) | 2008-09-30 | 2011-05-19 | Biotronik Vi Patent Ag | Implant made of a biodegradable magnesium alloy |
US8382824B2 (en) * | 2008-10-03 | 2013-02-26 | Boston Scientific Scimed, Inc. | Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides |
US20100125325A1 (en) * | 2008-11-20 | 2010-05-20 | Medtronic Vascular, Inc. | Stent With Cathodic Protection and Stent Delivery System |
US8231980B2 (en) * | 2008-12-03 | 2012-07-31 | Boston Scientific Scimed, Inc. | Medical implants including iridium oxide |
DE102008054845A1 (en) * | 2008-12-18 | 2010-07-01 | Biotronik Vi Patent Ag | Device and method for producing the same |
EP2403546A2 (en) * | 2009-03-02 | 2012-01-11 | Boston Scientific Scimed, Inc. | Self-buffering medical implants |
US8071156B2 (en) * | 2009-03-04 | 2011-12-06 | Boston Scientific Scimed, Inc. | Endoprostheses |
EP2408397B1 (en) | 2009-03-16 | 2014-09-24 | Cook Medical Technologies LLC | Hybrid stent and method of making such a stent |
US20100274352A1 (en) * | 2009-04-24 | 2010-10-28 | Boston Scientific Scrimed, Inc. | Endoprosthesis with Selective Drug Coatings |
US8287937B2 (en) * | 2009-04-24 | 2012-10-16 | Boston Scientific Scimed, Inc. | Endoprosthese |
US8954167B2 (en) * | 2009-05-26 | 2015-02-10 | Cardiac Pacemakers, Inc. | Helically formed coil for a neural cuff electrode |
US20110022158A1 (en) * | 2009-07-22 | 2011-01-27 | Boston Scientific Scimed, Inc. | Bioerodible Medical Implants |
US9433439B2 (en) * | 2009-09-10 | 2016-09-06 | Innovasis, Inc. | Radiolucent stabilizing rod with radiopaque marker |
US20110066223A1 (en) * | 2009-09-14 | 2011-03-17 | Hossainy Syed F A | Bioabsorbable Stent With Time Dependent Structure And Properties |
US8425587B2 (en) * | 2009-09-17 | 2013-04-23 | Abbott Cardiovascular Systems Inc. | Method of treatment with a bioabsorbable stent with time dependent structure and properties and regio-selective degradation |
EP2338534A2 (en) * | 2009-12-21 | 2011-06-29 | Biotronik VI Patent AG | Medical implant, coating method and implantation method |
US8801712B2 (en) * | 2010-03-08 | 2014-08-12 | Innovasis, Inc. | Radiolucent bone plate with radiopaque marker |
US8668732B2 (en) * | 2010-03-23 | 2014-03-11 | Boston Scientific Scimed, Inc. | Surface treated bioerodible metal endoprostheses |
EP2555811B1 (en) | 2010-04-06 | 2017-09-27 | Boston Scientific Scimed, Inc. | Endoprosthesis |
US20110270330A1 (en) * | 2010-04-29 | 2011-11-03 | Medtronic, Inc. | Diffusion bonded lead connector |
JP5577469B2 (en) | 2010-09-15 | 2014-08-20 | カーディアック ペースメイカーズ, インコーポレイテッド | Automatic selection of lead configuration for neural stimulation leads |
US10406009B2 (en) | 2010-09-15 | 2019-09-10 | Abbott Cardiovascular Systems Inc. | Bioabsorbable superficial femoral stent patterns with designed to break links |
EP2457601B1 (en) * | 2010-11-08 | 2015-07-22 | Biotronik AG | Marker composite and medical implant comprising an x-ray marker |
US10166128B2 (en) | 2011-01-14 | 2019-01-01 | W. L. Gore & Associates. Inc. | Lattice |
US9839540B2 (en) * | 2011-01-14 | 2017-12-12 | W. L. Gore & Associates, Inc. | Stent |
US8808350B2 (en) | 2011-03-01 | 2014-08-19 | Endologix, Inc. | Catheter system and methods of using same |
US8728563B2 (en) * | 2011-05-03 | 2014-05-20 | Palmaz Scientific, Inc. | Endoluminal implantable surfaces, stents, and grafts and method of making same |
US8996114B2 (en) | 2011-06-28 | 2015-03-31 | Cardiac Pacemakers, Inc. | Strain relief feature for an implantable medical device lead |
US8903509B2 (en) * | 2012-03-21 | 2014-12-02 | Cardiac Pacemakers Inc. | Systems and methods for stimulation of vagus nerve |
US9254212B2 (en) | 2012-04-06 | 2016-02-09 | Abbott Cardiovascular Systems Inc. | Segmented scaffolds and delivery thereof for peripheral applications |
WO2014055393A1 (en) | 2012-10-02 | 2014-04-10 | Cardiac Pacemakers, Inc. | Pinch to open cuff electrode |
US9114250B2 (en) | 2012-10-02 | 2015-08-25 | Cardiac Pacemakers, Inc. | Pinch to open cuff electrode |
US9931193B2 (en) | 2012-11-13 | 2018-04-03 | W. L. Gore & Associates, Inc. | Elastic stent graft |
US9144492B2 (en) | 2012-12-19 | 2015-09-29 | W. L. Gore & Associates, Inc. | Truncated leaflet for prosthetic heart valves, preformed valve |
US10279084B2 (en) | 2012-12-19 | 2019-05-07 | W. L. Gore & Associates, Inc. | Medical balloon devices and methods |
US9101469B2 (en) | 2012-12-19 | 2015-08-11 | W. L. Gore & Associates, Inc. | Prosthetic heart valve with leaflet shelving |
US9968443B2 (en) | 2012-12-19 | 2018-05-15 | W. L. Gore & Associates, Inc. | Vertical coaptation zone in a planar portion of prosthetic heart valve leaflet |
WO2014106023A1 (en) | 2012-12-28 | 2014-07-03 | Cardiac Pacemakers, Inc. | Stimulation cuff and implantation tool |
EP2956208B1 (en) | 2013-02-13 | 2021-01-13 | Cardiac Pacemakers, Inc. | Cuff electrode with integrated tendril |
US10842918B2 (en) | 2013-12-05 | 2020-11-24 | W.L. Gore & Associates, Inc. | Length extensible implantable device and methods for making such devices |
WO2015168016A1 (en) * | 2014-04-29 | 2015-11-05 | Stryker Corporation | Method for producing radiopaque medical implants |
US9943628B2 (en) | 2014-07-30 | 2018-04-17 | Medtronic Vascular Inc. | Welded stent with radiopaque material localized at the welds and methods |
US10238397B2 (en) | 2014-09-08 | 2019-03-26 | Stryker Corporation | Vaso-occlusive devices with in-situ stiffening |
US9827094B2 (en) | 2014-09-15 | 2017-11-28 | W. L. Gore & Associates, Inc. | Prosthetic heart valve with retention elements |
US9999527B2 (en) | 2015-02-11 | 2018-06-19 | Abbott Cardiovascular Systems Inc. | Scaffolds having radiopaque markers |
US9700443B2 (en) | 2015-06-12 | 2017-07-11 | Abbott Cardiovascular Systems Inc. | Methods for attaching a radiopaque marker to a scaffold |
JP2018524025A (en) | 2015-06-30 | 2018-08-30 | エンドロジックス、インク | Lock assembly for coupling guidewire to delivery system |
AU2016308055B2 (en) * | 2015-08-17 | 2019-02-14 | Boston Scientific Scimed, Inc. | Radioactive stent |
US20170216628A1 (en) * | 2016-02-03 | 2017-08-03 | University Hospital Ostrava | Methods and devices for stereotactic radiosurgery |
US10022255B2 (en) | 2016-04-11 | 2018-07-17 | Idev Technologies, Inc. | Stent delivery system having anisotropic sheath |
EP4233806A3 (en) | 2016-04-21 | 2023-09-06 | W. L. Gore & Associates, Inc. | Diametrically adjustable endoprostheses |
WO2019033342A1 (en) * | 2017-08-17 | 2019-02-21 | 鼎科医疗技术(苏州)有限公司 | Degradable metal stent |
US11020221B2 (en) | 2017-09-27 | 2021-06-01 | W. L. Gore & Associates, Inc. | Prosthetic valve with expandable frame and associated systems and methods |
CA3078606C (en) | 2017-10-31 | 2023-09-05 | W.L. Gore & Associates, Inc. | Medical valve and leaflet promoting tissue ingrowth |
CN109984864B (en) * | 2017-12-29 | 2020-07-17 | 先健科技(深圳)有限公司 | Stent for branch vessels |
DE102018218130A1 (en) | 2018-10-23 | 2020-04-23 | Karlsruher Institut für Technologie | Stent for implantation in a cavity of a human or animal body and method for producing an X-ray-opaque layer structure on a stent |
US11497601B2 (en) | 2019-03-01 | 2022-11-15 | W. L. Gore & Associates, Inc. | Telescoping prosthetic valve with retention element |
EP4081270A4 (en) * | 2019-12-26 | 2024-01-17 | Univ Columbia | Biomimetic polymeric composite for heart valve repair |
DE102020111669A1 (en) | 2020-04-29 | 2021-11-04 | Rheinisch-Westfälische Technische Hochschule (Rwth) Aachen | Graduated thin-film systems made of metal-ceramic composites for the coating of cardiovascular implants |
US11185741B1 (en) * | 2020-05-27 | 2021-11-30 | Callaway Golf Company | Method and system for utilizing radio-opaque fillers in multiple layers of golf balls |
WO2021247024A1 (en) * | 2020-06-03 | 2021-12-09 | Biovascular Therapeutics Pte Ltd | Radiopaque biodegradable metallic scaffold with a non-biodegradable coating, and which includes radial support rings and resiliently flexible, preferentially fracturable axial links therebetween |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3685059A (en) * | 1970-07-28 | 1972-08-22 | Gulf General Atomic Inc | Prosthetic blood circulation device having a pyrolytic carbon coated blood contacting surface |
US4086916A (en) * | 1975-09-19 | 1978-05-02 | Joseph J. Cayre | Cardiac monitor wristwatch |
US5669936A (en) | 1983-12-09 | 1997-09-23 | Endovascular Technologies, Inc. | Endovascular grafting system and method for use therewith |
US4699611A (en) | 1985-04-19 | 1987-10-13 | C. R. Bard, Inc. | Biliary stent introducer |
IT1202558B (en) | 1987-02-17 | 1989-02-09 | Alberto Arpesani | INTERNAL PROSTHESIS FOR THE REPLACEMENT OF A PART OF THE HUMAN BODY PARTICULARLY IN THE VASCULAR OPERATIONS |
US4800882A (en) * | 1987-03-13 | 1989-01-31 | Cook Incorporated | Endovascular stent and delivery system |
US5201901A (en) | 1987-10-08 | 1993-04-13 | Terumo Kabushiki Kaisha | Expansion unit and apparatus for expanding tubular organ lumen |
US4943346A (en) | 1988-09-29 | 1990-07-24 | Siemens Aktiengesellschaft | Method for manufacturing printed circuit boards |
US5258022A (en) * | 1989-07-25 | 1993-11-02 | Smith & Nephew Richards, Inc. | Zirconium oxide and nitride coated cardiovascular implants |
US5496359A (en) * | 1989-07-25 | 1996-03-05 | Smith & Nephew Richards, Inc. | Zirconium oxide and zirconium nitride coated biocompatible leads |
US5647858A (en) * | 1989-07-25 | 1997-07-15 | Smith & Nephew, Inc. | Zirconium oxide and zirconium nitride coated catheters |
CA2026604A1 (en) | 1989-10-02 | 1991-04-03 | Rodney G. Wolff | Articulated stent |
US5067491A (en) * | 1989-12-08 | 1991-11-26 | Becton, Dickinson And Company | Barrier coating on blood contacting devices |
CA2038488A1 (en) | 1990-03-19 | 1991-09-20 | Roger A. Olson | Process for optimizing corrosion protection of coated substrates |
US5222971A (en) | 1990-10-09 | 1993-06-29 | Scimed Life Systems, Inc. | Temporary stent and methods for use and manufacture |
EP0581866B1 (en) | 1991-04-24 | 1998-03-04 | Baxter International Inc. | Exchangeable integrated-wire balloon catheter |
US5234416A (en) | 1991-06-06 | 1993-08-10 | Advanced Cardiovascular Systems, Inc. | Intravascular catheter with a nontraumatic distal tip |
FR2677872A1 (en) | 1991-06-19 | 1992-12-24 | Celsa Lg | Device for assisting in the positioning of a filter for trapping thrombi |
US5269802A (en) | 1991-09-10 | 1993-12-14 | Garber Bruce B | Prostatic stent |
US5423849A (en) | 1993-01-15 | 1995-06-13 | Target Therapeutics, Inc. | Vasoocclusion device containing radiopaque fibers |
WO1994016646A1 (en) * | 1993-01-19 | 1994-08-04 | Schneider (Usa) Inc. | Clad composite stent |
WO1995003010A1 (en) | 1993-07-23 | 1995-02-02 | Cook Incorporated | A flexible stent having a pattern formed from a sheet of material |
JP2825452B2 (en) | 1994-04-25 | 1998-11-18 | アドヴァンスド カーディオヴァスキュラー システムズ インコーポレーテッド | Radiopak stent marker |
CA2147813A1 (en) | 1994-04-28 | 1995-10-29 | Richard Dixon | Intravascular prosthesis with anti-thrombogenic coating |
US5599576A (en) | 1995-02-06 | 1997-02-04 | Surface Solutions Laboratories, Inc. | Medical apparatus with scratch-resistant coating and method of making same |
US5674242A (en) * | 1995-06-06 | 1997-10-07 | Quanam Medical Corporation | Endoprosthetic device with therapeutic compound |
US5609629A (en) * | 1995-06-07 | 1997-03-11 | Med Institute, Inc. | Coated implantable medical device |
-
1996
- 1996-08-22 US US08/701,708 patent/US6174329B1/en not_active Expired - Lifetime
- 1996-11-12 NZ NZ299738A patent/NZ299738A/en unknown
- 1996-11-15 AU AU71779/96A patent/AU7177996A/en not_active Abandoned
- 1996-11-19 CA CA2190696A patent/CA2190696A1/en not_active Abandoned
- 1996-12-12 EP EP02007308A patent/EP1290984A3/en not_active Withdrawn
- 1996-12-12 DE DE69627143T patent/DE69627143T2/en not_active Expired - Lifetime
- 1996-12-12 EP EP96309057A patent/EP0824900B1/en not_active Expired - Lifetime
- 1996-12-18 JP JP33782096A patent/JPH1080492A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0824900B1 (en) | 2003-04-02 |
EP1290984A3 (en) | 2004-01-28 |
AU7177996A (en) | 1998-02-26 |
US6174329B1 (en) | 2001-01-16 |
EP0824900A2 (en) | 1998-02-25 |
JPH1080492A (en) | 1998-03-31 |
EP1290984A2 (en) | 2003-03-12 |
EP0824900A3 (en) | 1998-09-16 |
DE69627143D1 (en) | 2003-05-08 |
NZ299738A (en) | 1997-06-24 |
DE69627143T2 (en) | 2004-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6174329B1 (en) | Protective coating for a stent with intermediate radiopaque coating | |
US6099561A (en) | Vascular and endoluminal stents with improved coatings | |
US6387121B1 (en) | Vascular and endoluminal stents with improved coatings | |
US6355058B1 (en) | Stent with radiopaque coating consisting of particles in a binder | |
US7402173B2 (en) | Metal stent with surface layer of noble metal oxide and method of fabrication | |
US5824045A (en) | Vascular and endoluminal stents | |
KR100309485B1 (en) | Multi-layered Metal Stent | |
US6387123B1 (en) | Stent with radiopaque core | |
US8066763B2 (en) | Drug-releasing stent with ceramic-containing layer | |
US6478815B1 (en) | Vascular and endoluminal stents | |
EP1545395B1 (en) | Niobium stent | |
CA2442057C (en) | Medical device having radio-opacification and barrier layers | |
Mani et al. | Coronary stents: a materials perspective | |
US20100198336A1 (en) | Medical devices and methods of making the same | |
MXPA96006308A (en) | Protective coating for an endoprotesis with radiopaco coating interme |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |